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Abstract
Congenital heart defects (CHDs) occur in approximately 1% of live births and the etiology
has been associated with disturbances in cardiogenesis. However, the majority of research
examining CHDs relies on static morphological data, which does not elucidate how defects
alter cardiac function. I used Xenopus laevis embryos to examine the association between
CHDs and functional alterations using a novel imaging system that can obtain highresolution images through a non-invasive procedure. A high-speed video camera and
software were used to assess cardiac function, permitting functional characterization of late
Xenopus cardiogenesis. Verification of the imaging system’s ability to detect changes in
function was confirmed by exposing embryos to well-established agents that alter heart rate.
Additionally, significant functional changes were detected following exposure of embryos to
small molecules known to disrupt morphogenesis. The imaging system will be a useful
alternative to current imaging modalities for elucidating mechanisms underlying CHDs in
optically transparent embryos.

Keywords Xenopus, imaging, cardiogenesis, congenital heart defects, cardiac function,
morphogenesis
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Chapter 1

1

Introduction

The morphogenetic movements involved in cardiogenesis are well defined in many
animal species, including Xenopus laevis. There is an important need for understanding
cardiogenesis because cardiac development is a delicately orchestrated process that, if
disturbed, can result in the development of congenital heart defects (CHDs). Alterations
in cardiac morphology have been studied following manipulation of normal
organogenesis in many animal models, including Xenopus. However, how these
morphological changes can influence cardiac function is not as well understood.
Therefore, understanding the linkage between changes in cardiac morphology and cardiac
function could lead to important insight into clinical cases of congenital heart defects.
For the purpose of understanding the model organism we are using to study CHDs, I will
discuss the history and use of Xenopus in research.

1.1 Xenopus as a Model Organism
Xenopus laevis has proven to be an invaluable animal model and has previously been
used to provide a rich history for many aspects of early development. For example, a
recent publication in Nature Genetics examined the development of the kidney tubules
through novel tissue elongation mechanisms (Lienkamp et al., 2012). This article
addresses the requirement for planar cell polarity and non-canonical wnt signaling in the
proper formation of rosettes, which are multicellular structures used in elongation.
Through in vivo fluorescent imaging, this research team was able to visualize and identify
the role of rosette intercalation in kidney development. Xenopus have also been used as
an animal model to study organogenesis of the gut (Kenny et al., 2012). A key process in
understanding development involves examination of the morphological movements of
cells during embryonic development. To examine these movements, a research group
used a non-invasive in vivo imaging modality referred to as X-ray microtomography.
This work provided further insight into cellular movements during gastrulation
(Moosmann et al., 2013). Lastly, embryogenesis requires appropriate cell division
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orientation. Through experiments with Xenopus, mechanisms underlying symmetric cell
division were examined and discovered to be essential for tissue growth and spreading
(Woolner and Papalopulu, 2012).
Several Xenopus studies have shed light on mechanisms involved in congenital heart
disease. The examination of human patients suffering heterotaxy has identified a high
prevalence of rare genic copy number variations (Fakhro et al., 2011). Heterotaxy can
result in congenital heart defects (CHDs) involving the disruption of proper left-right
patterning. Five genes that result in disruption of left-right cardiac patterning were
identified in Xenopus using the candidate genes discovered from the patients. Additional
experiments demonstrated a novel signaling cascade associated with heterotaxy involving
Galnt11, which is a glycosylation enzyme (Boskovski et al., 2013). Galnt11 mediates the
activity of notch and was identified as a candidate gene involved in heterotaxy in human
patients. The notch signaling pathway was found to be essential for the appropriate
balance between motile and immotile cilia at the midline where those cilia are important
in the determination of laterality. Therefore, Xenopus studies are able to elucidate
potential mechanisms involved in the etiology of heterotaxy in humans.
The initial characterization of specific signaling molecules required for cardiogenesis was
first identified in Xenopus. These cardiogenic pathways include fgf (Amaya et al., 1993),
bmp (Shi et al., 2000), inhibition of the canonical wnt pathway (Schneider and Mercola,
2001), and activation of non-canonical wnt signaling (Pandur et al., 2002). The roles of
these signaling pathways will be discussed in greater detail in a later section.
Amphibians do not require a functional heart until later tadpole stages making it feasible
to study severe cardiac defects in early hearts (Kaltenbrun et al., 2011; Mohun et al.,
2000). Zebrafish are another animal species commonly used in developmental biology
that also possess this important feature. Furthermore, the availability of multiple
transgenic lines provides genetic tools that can facilitate the study of many diseases.
Another feature of Xenopus that is particularly useful for this project and for the study of
congenital heart defects is a feature that is shared with zebrafish and shell-less chick
cultures, which are also used to study cardiac development. That is the ability to view the
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heart without embryo manipulation due to the translucent nature of the tadpoles. By
simply viewing the embryo from the ventral side, the heart can be clearly resolved using
a microscope with the ventricle and truncus being easily distinguishable. Therefore, gross
morphological complications in cardiac development can be clearly viewed through liveimaging or by in situ hybridization using a myocardium specific antisense RNA probe to
detect cardiac mRNAs such as cardiac troponin I (cTnI) (Drysdale et al., 1994).
In summary, Xenopus laevis embryos can be used to investigate the possible effects that
CHDs may have on cardiac morphology and function as it relates to humans (Lohr and
Yost, 2000). A discussion of myocardial specification, morphogenesis, origin, and
structure is appropriate in understanding the advantage of using Xenopus for studying
cardiac development and will be discussed next.

1.2 Cardiogenesis in Xenopus laevis
1.2.1

Myocardial Specification

Initiation of cardiac development involves the specification of precardiac mesodermal
progenitors during gastrulation through signals from both the deep endoderm and
Spemann’s organizer in the dorsal mesoderm (Collop et al., 2006; Nascone & Mercola,
1995; Sater & Jacobson, 1989; Schneider & Mercola, 1999). Subsequently, the
expression of early transcription factors, such as nkx2.5 and gata4, are activated, helping
to specify the cardiomyocyte lineage (Haworth et al., 2008; Lohr and Yost, 2000). This
culminates in the formation of two bilaterally symmetrical heart patches located beside
Spemann’s organizer (Afouda and Hoppler, 2009; Collop et al., 2006; Lohr and Yost,
2000; Mohun et al., 2000).
Tinman, the homolog of Nkx2.5, was first characterized in Drosophila melanogaster to be
required for cardiac specification (Bodmer, 1993). The loss-of-function phenotype, in
Drosophila, includes a complete loss of the heart, hence the appropriate origin of the
name assigned to this gene. Subsequently, mouse models demonstrated that loss of
Nkx2.5 expression caused the inability of cardiac morphogenesis to develop past the
linear heart tube phase (Komuro and Izumo, 1993; Lyons et al., 1995). When Xenopus
embryos were microinjected with mRNAs encoding mutated nkx2.5 transcripts that were
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initially identified in human patients presenting with CHDs, the embryos had disrupted
cardiogenesis with conduction defects and abnormalities of the atrioventricular valve and
atrial septum similar to defects seen in human patients (Bartlett et al., 2007).
Interestingly, although tinman appears critical for early cardiogenesis, it was not one of
the genes recently identified as being efficient in directed differentiation of fibroblasts
into myocardial cells. Instead, other key early transcription factors were capable of
driving myocardial differentiation, including a combination of Tbx5, Gata4 and Mef2c
(Fu et al., 2013).
The expression and interplay of numerous signaling pathways is essential for proper
cardiogenesis and include, but are not limited to, inhibition of canonical wnt (Foley and
Mercola, 2005; Pandur et al., 2002; Schneider and Mercola, 2001), bone morphogenetic
protein (bmp) (Breckenride et al., 2001; Marvin et al., 2001), fibroblast growth factor
(fgf) (Alsan and Schultheiss, 2002; Deimling and Drysdale, 2011) and notch (Rones et
al., 2000).
The canonical and non-canonical wnt signaling pathways both serve a role in cardiac
specification (Dyer and Kirby, 2009b). Inhibition of the canonical wnt pathway is
required for cardiac induction, which was demonstrated through both over expression of
pathway components and small molecule antagonist studies (Schneider and Mercola,
2001). In contrast, non-canonical wnt signaling stimulates cardiac differentiation through
wnt11 in Xenopus and the non-canonical wnt pathway plays a role in repressing
canonical wnt signaling (Afouda et al., 2008; Pandur et al., 2002). The repression of
canonical wnt signaling is especially crucial in embryonic regions that display high levels
of bmp activity (Marvin et al., 2001). Furthermore, bmp signaling is necessary for
maintaining cardiac gene expression and differentiation of the myocardium following
repression of canonical wnt signaling (Monzen et al., 1999; Schultheiss et al., 1997; Shi
et al., 2000).
Research has demonstrated that fgf8 expression in chick is necessary for the expression
of genes essential in myocardial differentiation (Alsan and Schultheiss, 2002). Expression
of fgf8 resulted in increased expression of nkx2.5 and mef2c in regions with high
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expression of bmp2. Fgf signaling is also critical for cardiac differentiation throughout
early development in Xenopus (Deimling and Drysdale, 2011). Therefore, fgf plays an
evolutionarily conserved role in maintaining cardiac gene expression.
Notch signaling is responsible for mediating the balance between myocardial and nonmyocardial cell fates. Activation of notch results in a down regulation of genes that
culminate in myocardial differentiation, whereas inhibition of notch leads to myocardial
differentiation (Rones et al., 2000). These initial studies were done prior to the discovery
of the second heart field (see below) and thus this result could be related to regulating
differentiation timing in those lineages.

1.2.2

Cardiac Morphogenesis

Cardiac morphogenesis requires both the formation of the cardiac layers and the
myocardial movements required to form the mature heart. I will discuss both of these
topics in the following sections.

1.2.2.1

Functions of the Three Cardiac Layers

The heart has three layers that form its walls (Figure 1). The endocardium is the inner
layer surrounding the cardiac lumen (Kolker et al., 2000; Lohr and Yost, 2000; Mohun et
al., 2000). Surrounding the endocardium is the muscular layer, referred to as the
myocardium. The myocardial layer will originate as a layer that is one cell thick, but
progressively thickens during cardiac and embryonic development (Kolker et al., 2000;
Lohr and Yost, 2000). The outer layer of the heart facing the pericardial cavity is the
epicardium, which is formed last during cardiac looping (Kaltenbrun et al., 2011).
Regardless of morphological differences among vertebrates, there does appear to be
evolutionary conservation of the molecular mechanisms underlying organogenesis,
especially with respect to the heart (Bartlett et al., 2010; Lohr and Yost, 2000).
Conservation of cardiac development is even observed between vertebrates and
Drosophila melanogaster in which the heart is composed of merely a linear tube
responsible for circulating haemolymph (Bodmer and Venkatesh, 1998).
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Figure 1. The three layers of the heart. An illustrated depiction of a transverse section
of a Xenopus laevis embryo heart. The heart is comprised of the three red layers
suspended within the pericardium. The epicardium comprises the outer sheet while the
endocardium comprises the inner sheet. The myocardium can be found between the
epicardium and endocardium. Legend: E = endocardium; P = pericardium; M =
myocardium; Ep = epicardium

7

1.2.2.2

Myocardial Movements

Cardiac development is well documented in Xenopus and can be characterized using a
standardized embryonic staging system developed by Nieuwkoop and Faber (Nieuwkoop
and Faber, 1994).
Following cardiac specification, two bilaterally symmetrical heart primordia are formed
and proceed to migrate towards the ventral midline. Originally, the patches migrate
dorso-anteriorly following gastrulation movements, but will subsequently migrate
ventrally to the ventral midline during neurulation (Afouda and Hoppler, 2009; Lohr and
Yost, 2000).
Afterwards, the two specified heart patches commence fusing to form a single linear heart
primordium at stage 16 of development (Kolker et al., 2000; Lohr and Yost, 2000;
Mohun et al., 2000). For this to occur, the two bilaterally symmetrical heart patches of
myocardium located on either side of Spemann’s organizer are physically united and
suspended within the pericardial cavity forming a trough (Mohun et al., 2000). The term
trough represents the morphology of the myocardium, which is initially a flat sheet, but
upon separation from the endoderm commences to pinch and invaginate to form a Vshaped anlagen. Next, the trough of myocardial tissue commences surrounding and
enclosing a single-cell thick endocardial tube. Eventually, the resultant linear cardiac tube
consists of a myocardial layer surrounding the thin endocardial tube (Figure 1). Cardiac
differentiation initiates during cardiac tube closure at stage 27 and this differentiation can
be defined by the expression of genes necessary for end function (Figure 2A) (Kolker et
al., 2000; Lohr and Yost, 2000; Mohun et al., 2000). Subsequently, by stage 33, the
myocardial tube has completely closed, signaling the complete formation of the heart
tube (Figure 2B).
After formation of the linear heart tube, the heart undergoes dorsal and rightward looping
beginning at stage 33/34 (Figure 2C), resulting in the formation of an anticlockwise spiral
or S-shaped tube by stage 35 (Figure 2D) (Afouda and Hoppler, 2009; Kolker et al.,
2000; Lohr and Yost, 2000; Mohun et al., 2000). This non-linear tube consists of the
outflow tract (also referred to as the truncus arteriosus) in the anterior end while the atria
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form the posterior end (Mohun et al., 2000). Cardiac looping is an essential process for
subsequent valve formation and the development of the three cardiac chambers. The three
chambers are comprised of the left atrium, right atrium, and a single ventricle. An
additional sheet of cells, collectively known as the epicardium originating from the
proepicardial anlagen, will develop and surround the muscular myocardium during
cardiac looping (Jahr et al., 2008; Kaltenbrun et al., 2011). Subsequently, coordinated
myocardial contractions cause the primitive heart to commence beating at approximately
stage 35 (Lohr and Yost, 2000; Warkman and Krieg, 2007).
By stage 41, the truncus arteriosus and ventricle have thickened through the addition of
layers and the ventricle becomes highly trabeculated, but not septated as is the case in
mammals (Figure 2E) (Kolker et al., 2000; Lohr and Yost, 2000). Trabeculation refers to
luminal projections of muscle located within the ventricle that aid in increasing the force
of cardiac contraction. By stage 45/46, the distinct cardiac structures are easily
discriminated. The spiral valve, located within the outflow tract, and the atrioventricular
valve have fully formed at this developmental period (Figure 2F) (Bartlett et al., 2010;
Kolker et al., 2000; Lohr and Yost, 2000; Mohun et al., 2000). The spiral valve is
required for separation of oxygenated and deoxygenated blood in the single outflow tract
and resembles the aorticopulmonary septum observed in humans (Kolker et al., 2000;
Sadler, 1990). Lastly, an atrial septum separating the left and right atria extends from the
dorsal wall resulting in partial atrial septation (Lohr and Yost, 2000; Mohun et al., 2000).
Therefore, the major elements comprising the mature heart can be considered complete
by stage 46, which, at room temperature, is approximately four and a half days after
fertilization (Kolker et al., 2000).
Recent developments have demonstrated added complexity to cardiac development as the
cells that contribute to the heart do not all originate from one single population, as
discussed next.
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Figure 2. Cardiac development in Xenopus embryos. Confocal images of fixed
Xenopus embryos using anti-tropomyosin staining for stages 27-33 and anti-cardiac
troponin T staining for stages 35-46. Images are displayed from the ventral side of the
embryo. Panel 2A depicts the closing of the cardiac anlagen to form a single cardiac
primordium. This developmental interval also represents the initiation of cardiac
differentiation. Next, panel 2B depicts the complete closure of the primordium to form a
single linear heart tube consisting of an endocardial and myocardial layer. By panel C,
the heart has begun to undergo dorsal and rightward looping and subsequently this
process is complete by panel D. During this period, the ventricle and truncus arteriosus
become distinguishable from the ventral side. Afterwards, the ventricle becomes highly
trabeculated, which is depicted in panel 2E. The Xenopus embryo is primarily finished
cardiac development by panel 2F, with completion of partial septation of the atria. Scale
bar represents 100µm. Image was adapted from Kolker et al. (2000) with omission of the
whole mount embryo depictions from the original figure and addition of arrows denoting
the anterior-posterior axis. Legend: TA = truncus arteriosus; V = Ventricle; A = Atria; T
= Trabeculation
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1.2.3

Secondary Heart Field

The heart was initially believed to originate from a single population of cardiac
progenitors. However, research over the last decade has identified the presence of two
separate populations of cardiac progenitors that are both required for proper cardiac
development (Dyer and Kirby, 2009b; Meilhac et al., 2003; Zaffran and Kelly, 2012).
The primary heart field is the region that gives rise to the initial cardiac tube, whereas the
cells of the secondary heart field contribute to the developing myocardium by migrating
into the arterial and venous poles of the original cardiac tube (Dyer and Kirby, 2009b).
The partitioning of progenitors into the two pools is believed to originate either at
gastrulation or earlier in development (Zaffran and Kelly, 2012). The cell population of
the left ventricle is derived from the primary cardiac cell group, whereas the outflow tract
and right ventricle originate from cells arising from the second population (Meilhac et al.,
2003). The atria are thought to arise from a mixture of the two lineages (Dyer and Kirby,
2009b).
The presence of a secondary heart field has now been confirmed in Xenopus (Brade et al.,
2007). The secondary heart field (or second heart field) serves a similar purpose to the
mouse model although the relative contributions of each lineage to the different chambers
has not been worked out. The second heart field provides cells required for expansion and
extension of the linear heart tube at the arterial and venous poles.
Expression of Islet-1 (isl-1) can be used to identify early cardiac progenitors within the
mesoderm and this expression is conserved in Xenopus (Dyer and Kirby, 2009b; Sun et
al., 2007). Extensive research in Drosophila, amphibians, amniotes, and mammals has
contributed to understanding the importance of this gene in the establishment of a mature
heart (Brade et al., 2007; Dyer and Kirby, 2009b). Isl-1 is expressed in all cardiac
progenitors, but its expression is lost in the primary heart field while being maintained in
the secondary heart field (Dyer and Kirby, 2009b). Therefore, the secondary heart field
can be identified based on the expression of Isl-1, which is maintained in the second heart
field and down regulated in the primary heart field once differentiation is complete.
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The expression of Nkx2.5 contributes to the differences in temporal expression of Isl-1
and primarily acts through inhibition of Smad1, which leads to further inhibition of Bmp
signaling (Prall et al., 2007). This network allows for the differentiation of the primary
population while the secondary lineage is held in a proliferative progenitor state until a
later development period. The expression of Isl-1 and Nkx2.5 is not exclusive between
the two populations, but rather the difference lies in the temporal regulation of
differentiation (Dyer and Kirby, 2009b).
Addition of cells from the secondary heart field lengthens the outflow tract and probably
serves a role in the proper rotation and alignment of the cardiac regions (Yelbuz et al.,
2002b). The inability to maintain the progenitor pool results in a premature accumulation
of myocardial cells to the initial cardiac tube (Dyer and Kirby, 2009b). Several loss of
function studies have demonstrated the essential role that the second heart field serves in
formation of a mature heart. For example, Isl-1 knockout mice lack the development of
an outflow tract, right ventricle, and much of the atria (Cai et al., 2003). Ablation of the
secondary heart field in chick embryos resulted in several cardiac defects including
overriding aorta, pulmonary atresia, and coronary artery anomalies indicating that the
second heart field is necessary for proper orientation of the outflow tract (Ward et al.,
2005). In the presence of antisense morpholinos targeting isl-1 in Xenopus, there was
abnormal cardiac looping and the resulting hearts were reduced in size (Brade et al.,
2007).
Canonical Wnt signaling is maintained in the second heart field following the
development of the initial cardiac tube. The loss of Wnt signaling has been associated
with a reduced Isl1 positive cell population (or second heart field), resulting in outflow
tract and right ventricular defects in mice (Cohen et al., 2007).
Sonic hedgehog (shh) is required for arterial pole development through its role in
maintaining the secondary heart field (Dyer and Kirby, 2009a). Shh signaling is required
for cell proliferation in the second heart field and loss of this signaling results in the
inadequate ability to expand the arterial pole. Absence of Shh signaling has been linked
to cardiac defects in mice and zebrafish, including patterning abnormalities in the outflow
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tract and disruption of neural crest cell development, which may be the cause of the
outflow defects (Schilling et al., 1999; Washington Smoak et al., 2005).
Fgf serves a role in the addition of cells originating from the second heart field to the
expanding outflow tract in mice to regulate morphogenesis (Park et al., 2008; Zhang et
al., 2008). Fgf expression in the second heart field is required for the production of
extracellular matrix, expression of Tgfβ, and expression of Bmp in the outflow tract of
mice (Park et al., 2008). Disruption of downstream Fgf signaling in mice resulted in
outflow tract defects, such as improper expansion, defective alignment, hypoplasia, and
septal defects (Zhang et al., 2008).
Conditional Notch knockouts through Mef2c and Isl-1 cre recombinase drivers resulted in
an increased incidence of right ventricular and outflow tract defects in mice (High et al.,
2009). The use of these cre recombinase lines allowed for the knockout of Notch
signaling exclusively in cells of the second heart field. Therefore, the defects seen are
intrinsic to the secondary heart field cell population.
My thesis is aimed at assessing cardiac function, therefore, I will now discuss the mature
embryonic Xenopus heart.

1.2.4

Circulation and Cardiac Structure

Cardiac blood flow in Xenopus commences at the posterior end of the heart where the
partially septated atria separate pulmonary and systemic venous returns (Figure 3) (Lohr
and Yost, 2000; Mohun et al., 2000). The larger right atrium collects the systemic venous
returns while the pulmonary venous returns accumulate in the smaller left atrium.
Therefore, there is separation of oxygenated and deoxygenated blood. Afterwards,
erythrocytes circulate through the atrioventricular valve into a single trabeculated
ventricle (Lohr and Yost, 2000). In contrast to birds and mammals, Xenopus only have a
single ventricle and atrioventricular valve for accommodating both the pulmocutaneous
and systemic circulation. Subsequently, circulation proceeds from the ventricle to the
truncus arteriosus, which contains two valves, including the spiral valve. These valves
direct blood flow based on the relative resistance of the vasculature to either the
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pulmonary, carotid, or systemic arteries (Kolker et al., 2000). Conversely, the
mammalian four-chambered heart consists of both an aorta and pulmonary artery to
separate blood flow.
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Figure 3. A confocal microscopy image of a morphologically mature embryonic
Xenopus
heart.
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1.3 Congenital Heart Defects
As discussed above, cardiac development is a highly coordinated process. Therefore, it is
not surprising that there is a strong association between disruptions during early
cardiogenesis and the occurrence of congenital heart defects (CHDs) (Khoshnood et al.,
2012). CHDs represent the most prevalent abnormality seen at birth and accounts for a
substantial proportion of morbidity and mortality. Currently, estimations predict that
CHDs affect approximately 1% of live births (Hoffman and Kaplan, 2002).
Congenital heart defects can manifest in numerous manners. Examples of CHDs in
humans include heterotaxy, atrial septal defects (ASDs), functionally univentricular
hearts, anomalies of the venous return, and ventricular septal defects (VSDs), which is
the most prevalent CHD (Khoshnood et al., 2012). Furthermore, the outcome that the
defect may have on cardiac function can vary depending on the defect.
The origin of CHDs can be explained by both genetic and environmental factors. CHDs
with a genetic basis have been linked to disease states including Down’s syndrome,
Noonan syndrome, Holt-Oram syndrome, DiGeorge syndrome, Axenfeld-Reiger
syndrome, and CHARGE syndrome (Bosman et al., 2015; Kaltenbrun et al., 2011). Our
understanding of the single gene mutation basis of CHDs in humans originated with the
gene NKX2.5, the human homologue of Tinman discussed previously (Schott et al.,
1998). Human patients identified to be heterozygous for an autosomal dominant mutation
that resulted in CHDs were evaluated and the mutation was mapped to the NKX2.5 locus.
The mutation could be associated with VSDs, ASDs, tetralogy of Fallot, pulmonary
atresia, ventricular hypertrophy, or subvalvular aortic stenosis and all patients
demonstrated atrioventricular conduction defects. Importantly, as shown eloquently in
this study, a single mutation can result in different phenotypes among affected patients.
Since the discovery of tinman, an abundance of research has determined links between
disruptions in numerous genes and the development of congenital heart disease. These
include Gata4, Tbx1, Tbx5, Tbx20, Zic3, Pitx2, and FoxC1 (Kaltenbrun et al., 2011).
Most of these mutations share common characteristics, such as dominant inheritance and
result in defects in cardiac structure and conduction.
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1.4 Disruption of Cardiogenesis
Since disruption of cardiogenesis has been associated with the incidence of congenital
heart defects, exposure to small molecules targeting specific morphogenetic pathways
can be used to generate cardiac abnormalities (Khoshnood et al., 2012). I utilized several
of these in my thesis and I will now provide an overview of the small molecules used and
the pathways they impact.

1.4.1

Blebbistatin

Myosins comprise a group of motor proteins that, in combination with actin, use the
energy released upon ATP hydrolysis to drive contraction (Allingham et al., 2005). The
composition of myosins can be separated into four components: two heavy chains and
two light chains (Tullio et al., 1997). Non-muscle myosin (NM) is present within muscle
cells along with muscle myosin and is fundamental for actin cross-linking and contraction
(Vicente-Manzanares et al., 2009). NM II, an isoform of NM, serves a role in the
regulation of the actin cytoskeleton as well as in cell migration, adhesion, cytokinesis and
cellular morphogenesis (Tullio et al., 1997; Vicente-Manzanares et al. 2009). Non-muscle
myosin’s role in cardiac development has been demonstrated through knockout
experiments where NM-deficient mice displayed an increased incidence of VSDs and
abnormalities of the outflow tract (Tullio et al., 1997). Numerous kinases have been
discovered to be required for the phosphorylation and activation of the regulatory light
chain of NM-II, including ROCK and myosin light chain kinase (MLCK) (VicenteManzares et al., 2009).
Blebbistatin is a small molecule that acts as a non-competitive inhibitor of non-muscle
myosin II activity (Allingham et al., 2005; Dou et al., 2007; Swift et al., 2012).
Specifically, blebbistatin binds to myosin causing it to stabilize in the myosin-ADP-Pi
complex state. Myosin maintains low affinity for actin due to the inability of myosin to
release the phosphate. Hence, myosin does not bind to actin, which blocks the forcegenerating step required for a contraction (Dou et al., 2007; Swift et al., 2012). This
effect is only observed with the (-)-blebbistatin enantiomer, while (+)-blebbistatin can
serve as a control due to its lower binding affinity (Allingham et al., 2005). Blebbistatin
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has been demonstrated in mice to inhibit cardiac contractions independently of Ca2+
influx (Dou et al., 2007).

1.4.2

Rockout

The Rho family of GTPases is essential in cell morphogenesis, cell migration, and
organogenesis, including a necessary role in cardiac development (Morckel et al., 2012;
Wei et al., 2002). The signaling activity of Rho is dependent on ROCK (Rho-associated
kinases), which represents a group of serine/threonine kinases (Yarrow et al., 2005).
Upon activation by Rho, ROCK is capable of phosphorylating downstream proteins
including myosin light chain (MLC). However, ATP is required for these kinases to
phosphorylate downstream effectors and initiate the appropriate response.
Rockout is a small molecule that inhibits Rho-associated kinases, specifically ROCK-II
(Morckel et al., 2012; Yarrow et al., 2005). Rockout acts as a competitive inhibitor of
ATP binding to ROCKII, thereby effectively decreasing phosphorylation of MLC.

1.4.3

Retinoic Acid and Retinoic Acid Receptor Antagonist

All-trans retionic acid is the biologically active form of vitamin A (Collop et al., 2006).
The endogenous synthesis of retinoic acid (RA) primarily depends on the enzyme
retinaldehyde dehydrogenase 2 (Raldh2) (Hochgreb et al., 2003; Xavier-Neto et al.,
1999), while Cyp26 is the enzyme responsible for RA degradation (Haselbeck et al.,
1999; Hollemann et al., 1998).
RA is essential for the regulation of numerous developmental processes, including
cardiac development (Collop et al., 2006; Deimling and Drysdale, 2009; Glass and
Rosenfeld, 2000; Ross et al., 2001; Zile, 2001). Retinoic acid traverses the cellular
membrane, due to RA’s lipophilic properties, then proceeds to form a complex in the
nucleus with retinoic acid receptors (RARs) and retinoid X receptors (RXRs) that are
bound to DNA. Subsequently, this complex can act as a transcription factor in the
nucleus. In particular, this ligand-activated complex bound to retinoic acid responsive
elements (RAREs) recruits co-activators that alter gene expression (Glass and Rosenfeld,
2000; Ross et al., 2001; Zile, 2001). In the absence of retinoic acid, or in the presence of
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retinoic acid receptor antagonists, the RAR/RXR heterodimer is still bound to the
response elements on DNA, but represses the expression of RA-responsive genes
(Deimling and Drysdale, 2009).
Previous experiments have demonstrated that RA is essential in the development of the
heart of Xenopus, mammals, and birds (Collop et al., 2006; Drysdale and Crawford,
1994; Jiang et al., 1999; Keegan et al., 2005; Smith et al., 1997; Twal et al., 1995;
Xavier-Neto et al., 2000). RA is required for the initial restriction of cardiac progenitor
cells in zebrafish, therefore regulating the quantity of progenitor cells. Retinoic acid is
also required for the subsequent closure of the heart tube from the symmetrical heart
regions in Xenopus (Collop et al., 2006).

1.5 Assessing Cardiac Function
1.5.1

Rationale

The information provided demonstrates that cardiac development in Xenopus is useful for
the study of CHDs. For my project, I chose to evaluate a novel approach to studying
CHDs, which involves assessing cardiac function in Xenopus embryos.
However, my project relies on a relationship between cardiac morphology and function to
characterize CHDs, therefore I will first discuss this link.

1.5.2

Relationship Between Cardiac Morphology and Function

Although the widely held belief is that morphology affects function, the reverse also
appears to be true. Proper cardiac function is essential for normal morphogenetic
developments. Disruption of haemodynamic forces in zebrafish resulted in cardiac
morphological defects such as chamber, valve and cardiac looping abnormalities (Hove et
al., 2003). Lack of myocardial function during late heart development resulting from
absence of a heartbeat caused disruptions in the formation of the atrioventricular
endocardial cushions (Bartman et al., 2004). Also, zebrafish with a reduced circulation
had cell shape alterations, ultimately resulting in a decrease in cardiomyocyte elongation,
which is required for proper ventricle formation (Auman et al., 2007).
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Thus, cardiac function and morphology are inter-related and both are crucial for the
proper maintenance of the other. Therefore, to start understanding this relationship, I
studied cardiac function in Xenopus using video imaging in both normal hearts and in
those with specific morphogenetic defects to begin examining the link between cardiac
function and morphology.

1.5.3

Cardiac Function Terminology

My project primarily focused on cardiac function analysis. However, to understand the
cardiac function experiments, I will first discuss common terminology that is used to
characterize this process.
During a cardiac cycle, two major phases can be easily identified. End-diastole refers to
the time point in the cardiac cycle when the maximum blood volume is contained within
the ventricular cavity. At this point, the dimension of the ventricle is at its largest and this
period is immediately before a cardiac contraction. In contrast, end-systole refers to the
point in the cardiac cycle when the minimum amount of blood is present in the
ventricular cavity. The dimension of the ventricle is also at its minimum and this occurs
directly after a complete cardiac contraction.
An entire cardiac cycle can be used to compute the heart rate. Heart rate is measured in
beats per minute (bpm) and can be calculated by determining the number of cardiac
cycles spanning a minute.
Furthermore, cardiac function can be quantified through parameters such as thickness of
the ventricular wall, ejection fraction, stroke volume, and cardiac output. Ventricular wall
thickness is a measure of the distance from the endocardial border to the epicardial
border. Ejection fraction refers to the percentage of blood that is ejected as a ratio of that
contained at end-diastole, which is equivalent to the percentage of blood no longer
present at end-systole. Similarly, stroke volume is a measure of the blood volume that is
ejected after a complete cardiac contraction. Cardiac output is a measure of the volume of
blood pumped by the heart per minute and can be calculated by multiplying the stroke
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volume by the heart rate. It is important to note that some of these are the same
parameters that are used to assess cardiac function in human patients.

1.5.4

Previous Literature Examining Cardiac Function

The study of cardiac function not only requires knowledge of terminology, but also
familiarity with the research that has emerged in this field. However, research focusing
on CHDs is far more limited with respect to functional examination than compared to
data based on static morphological findings. As for the studies that have analyzed cardiac
function, these have primarily focused on other animal models, such as the chick (Li et
al., 2012) and zebrafish (Gao et al., 2012).
Previous research on cardiac development using Xenopus can be divided into static
morphological experiments and real-time in vivo imaging. The majority of research has
simply used whole mount in situ hybridization and standard microscopy to document the
images (for example, Collop et al., 2006; Deimling and Drysdale, 2009; Grover, 2009;
Halabi, 2013). Additional imaging modalities used with respect to fixed Xenopus
embryos include confocal microscopy (Jahr and Männer, 2011; Kolker et al., 2000),
scanning electron microscopy (Jahr and Männer, 2011; Jahr et al., 2008), and histological
sections used to generate 3D reconstructions (Jahr et al., 2008; Mohun et al., 2000; Yelin
et al., 2007b).
In contrast, cardiac in vivo imaging of live Xenopus laevis has been limited, but does
include imaging modalities such as echocardiography, involving the use of 2D imaging
and pulse-wave Doppler ultrasound to generate high frequency sounds waves to produce
an image (Bartlett et al., 2010). Studies examining adult Xenopus hearts used modified Xrays, which produced motion images by exploiting the differences in attenuation of
tissues to X-radiation (Szigeti et al., 2014). Another technique used was Third Harmonic
Generation (THG) utilized to visualize erythrocyte velocity and other hemodynamic
properties within the tail vessels of Xenopus embryos; however this could potentially be
modified to measure flow velocity in the aortic branches (Dietzel et al., 2014). THG uses
similar principles to fluorescent microscopy and employs a label-free method in which a
pulsing laser induces photons to be released from the biological tissue, such that an image
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can be obtained. Variations of optical coherence tomography (OCT) have also been used,
taking advantage of various frequencies of light and the varying level of optical scattering
within different tissues (Boppart et al., 1997; Mariampillai et al., 2007; Yang et al., 2003;
Yazdanfar et al., 1997; Yelin et al., 2007b). Similarly, spectrally encoded confocal
microscopy exploits the property of reflectance of near infrared light to penetrate through
to deeper tissues (Yelin et al., 2007b). Hemoglobin contrast subtraction angiography
utilizes the endogenous absorptive property of hemoglobin to generate a flow contrast
that enhances visualization of cardiac chambers (Deniz et al., 2012). An additional
technique used for in vivo live imaging of Xenopus is intrathoracic cardiac recording that
employs the use of electrodes inserted in the thorax to examine electrical conduction
(Bartlett et al., 2004).
However, these imaging modalities require specialized and expensive equipment.
Therefore, my project utilized a novel imaging system that offers the advantages of being
relatively inexpensive as it does not require specialized training and utilized relatively
inexpensive equipment. In the following sections, I will introduce this video imaging
system utilized for examining cardiac development.

1.5.5

History of the Novel Imaging System

Previously, the imaging system we have utilized was used to examine cardiac function in
chick embryos. Experiments were undertaken to examine early cardiogenesis in the chick
and to study crucial developmental intervals that determine proper development (Yelbuz
et al., 2002a). A recent publication using a similar system was published examining chick
hearts at numerous developmental time points in order to generate a comprehensive atlas
of the heart (Al Naieb, 2013). The research team used the same equipment used in my
study to observe real-time cardiac development in the chick (Orhan et al., 2007).

1.6 Rationale & Hypothesis
1.6.1

Rationale

A majority of previous experiments examining congenital heart defects in Xenopus based
their findings on static morphological data. For example, our lab has exposed Xenopus

22

embryos to various small molecules and documented their ability to alter cardiac
development (Collop et al., 2006; Deimling and Drysdale, 2011; Grover, 2009; Halabi,
2013). Whole mount in situ hybridizations using probes against cTnI mRNA were used to
identify myocardial tissue and, based on static observations, it was apparent that there
were disruptions in cardiac morphology after treatment with specific small molecules.
However, static morphological data is not necessarily indicative of altered cardiac
function. Therefore, research into functional differences could prove extremely useful for
the study of CHDs as it relates to humans where functional assessments are a key part of
patient diagnosis.
I propose to test for potential changes in cardiac function and predict significant changes
in cardiac performance resulting from CHDs. As well, I propose to document normal
cardiac function in Xenopus laevis embryos using the novel video imaging system that
provides higher resolution images compared to other commonly used imaging modalities.
This video system is capable of obtaining high frame rates, which is useful when imaging
a beating heart. I find that this novel imaging system and software can be a useful adjunct
for the study of CHDs.

1.6.2

Hypothesis

I hypothesized that disruptions in cardiac morphology would result in significant changes
in early cardiac function. Specifically, reductions in ventricular morphology would result
in reductions in cardiac function, whereas increases in ventricular morphology would
correspond to increases in cardiac function.
Furthermore, I hypothesized that this video imaging system would have the ability to
accurately analyze ventricular function in Xenopus laevis embryos. This would allow for
this imaging system to become a useful alternative to other imaging equipment for
examining and characterizing functional alterations following disruption of
cardiogenesis.
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Chapter 2

2

Materials and Methods

2.1 Embryo Collection
The embryos collected for experiments, not involving the transgenic animals, were
gathered from matings of wild type Xenopus laevis males and females obtained from
Xenopus 1 (Dexter, MI). The Nkx2.5-GFP transgenic females were obtained from the
National Xenopus Resource (Woods Hole, MA). Wild type males were used as the sperm
source regardless of whether the female was wild type or transgenic. The animal handling
protocols for this thesis were approved by the Animal Care Committee at the University
of Western Ontario, Canada (Protocol #: 2011-015).
Embryo collection firstly involved intramuscular injection of 700 international units (IU)
of human chorionic gonadotropin (hCG) (Chorulon) into a sexually mature female
Xenopus laevis to induce ovulation. After injection, the Xenopus were incubated
overnight at a temperature ranging from 16° - 18°C.
To obtain fresh testes, I euthanized sexually mature wild-type Xenopus laevis. The
euthanization protocol involved submerging the frog in water containing MS-222
(Tricaine; 3-aminobenzoic acid ethyl ester) (Sigma). Following anesthetization, the spinal
cord was initially severed using scissors and pithing was undertaken to destroy the spinal
cord. The testes were dissected out and maintained at 4°C in a petri dish containing 200%
Steinberg’s solution.
Squeezing of the females to gather ovum involved placing a small amount of 80%
Steinberg’s solution on a sterile petri dish. Eggs were squeezed into the dish and then
fertilized in vitro by addition of a piece of minced testes. After fertilization was
completed, embryos were de-jellied using 2.5% cysteine (pH 8.0 dissolved in distilled
H2O) (Bioshop). Subsequently, embryos were maintained in 20% Steinberg’s solution
(NaCl, KCl, MgSO4, Ca(NO3)2, Tris-HCl, distilled H2O) unless otherwise treated. All
embryonic staging corresponded to Nieuwkoop and Faber’s Normal Table of Xenopus
laevis (Nieuwkoop and Faber, 1994).
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2.2 Mounting and Live Imaging of Embryos
An embryo mounting technique, which was initially described by Kieserman et al. was
developed using 0.8% low-melting point (LMP) agarose (Life Technologies) (Kieserman
et al., 2010). This embedding procedure allowed me to maneuver the live embryo to
visualize the ventral side without manipulation or anesthetization to obtain in vivo realtime cardiac images (Figure 4). The LMP agarose was dissolved in 1/3x MMR (4M
NaCl, 1M KCl, 1M MgSO4, 1M CaCl2, 1M Hepes, 0.5M EDTA, distilled H2O) to obtain
the proper concentration.
The procedure involved placing an individual embryo into a small amount of LMP
agarose. Next, the embryo was flipped onto its dorsal side so the ventral side and heart
could be viewed easily. The agarose was then allowed to solidify and extra 1/3x MMR
was added to prevent embryo desiccation. Embedding in the LMP agarose allowed for
accurate cardiac imaging by largely eliminating motion artifacts, while requiring no
embryo manipulation. Hence, this procedure permitted long-term imaging as well as reuse of the identical embryo for subsequent measurements in longitudinal or acute
exposure studies.
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Figure 4. Mounting of Xenopus embryos for live cardiac imaging. Xenopus laevis
embryos (red brace) of various stages were mounted using the protocol outlined by
Kieserman et al., which embedded living embryos in 0.8% low-melting point agarose
(blue arrow). This was performed in a petri dish and the embryo was later immersed in a
salt solution to prevent desiccation. Embryos were maneuvered before the agarose
solidified so the ventral side was easily viewable. Afterwards, in vivo cardiac images of
live embryos were obtained. The heart is located above the gut and is outlined by the red
box in the image. This technique was selected based on the fact that motion artifacts were
largely eliminated while causing no negative cardiac repercussions.
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2.3 IO Imaging System & HeartMetrics Program
2.3.1

Equipment

Both the imaging system and the cardiac function analysis program were obtained from
IO Industries (London, Ontario). The equipment includes the DVR Express Core that
captures the images from a Flare 2M360-CL colour video camera. The high-speed colour
video camera is capable of obtaining a maximum of 359 frames per second (fps). The
user can balance the frame rate and resolution to optimize images that are appropriate for
the purpose of the experiment. For my experimental purposes, I selected a frame rate of
318.2 fps. The image capture software was designed to use hemoglobin as a contrast
filter. The software can alter the image such that areas with blood appear black whereas
areas depleted of blood are unaffected. However, additional alterations had to be
performed to better image the Xenopus embryo so that the videos could be optimized
prior to examining cardiac function.
The camera was mounted onto a stereomicroscope (Leica MZ12 or Leica M205 FA) and
calibration files corresponding to the microscopes were created. These calibration files
were applied to the videos for the purpose of obtaining accurately scaled measurements.
The camera feeds the video data to the DVR Express Core, which processes the images
and sends the information to the computer software. The data analysis programs included
HeartMetrics for guiding cardiac functional measurements and Microsoft Excel for
computing functional measurements using algorithms and coordinates generated by
HeartMetrics.

2.3.2

Program Procedure

Embryos were mounted and prepared for imaging according to the procedure described
above (Kieserman et al., 2010). The heart could be observed without manipulation of the
embryo since Xenopus embryos are relatively translucent at the time of cardiac imaging.
Next, the embryo was then placed under a steremicrooscope and at this point, the heart
was visible allowing the use of the HeartMetrics program and Flare camera.
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After obtaining the videos, the files underwent a LUT (lookup table) transformation,
which assisted in enhancing the contrast between the ventricular cavity and the
ventricular wall based on the hemoglobin contrast image. Next, several labeling and
selection functions of the HeartMetrics program were used. Labeling included the
marking of seven to eight relatively equidistant points to trace the endocardial and
epicardial borders during both end-systole and end-diastole. This was performed
manually by the user for four end-diastole and three end-systole images and averaged for
calculation of functional measurements. Subsequently, this data was exported to
Microsoft Excel, which automatically used the algorithms in combination with the
coordinates generated by HeartMetrics to calculate cardiac functional parameters.

2.3.3

Overview of the Imaging System

Colour images captured by the Flare camera are processed using a hemoglobin contrast
filter to create monochromatic video files. This allows for regions containing
hemoglobin, for example the ventricular cavity, to appear dark. In contrast, white regions
signify little to no red colour due to the absence of hemoglobin, such as the ventricular
wall. Furthermore, there are cardiac structures that appear grey signifying regions with
low perfusion that primarily represent areas with trabeculation. Regions with a high
density of trabeculation are considered contiguous with the ventricular wall and omitted
from the dimensions of the ventricular cavity. It is important to note that due to the
natural morphology of the Xenopus embryo, some areas that are not examined may
appear to have variations in these shades as well, for example, the gut appears black.
A multitude of user functions are available for the HeartMetrics program (Figure 5). For
the purposes of this project, the functions predominantly used included manually setting
the time frame for four end-diastoles and three end-systoles. This allowed for heart rate to
be computed. Manual labeling of the ventricle at end-diastole and end-systole were
performed for both the epicardial and endocardial borders (Figures 6 and 7). The
coordinates associated with the labels allowed for the calculation of other parameters,
such as stroke volume, cardiac output, and ventricular wall thickness. A LUT
transformation can be applied to increase the contrast of the image allowing for more
accurate labeling of the ventricular borders.
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Figure 5. Functions available for the HeartMetrics program. Multiple functions are
available for experimenters using HeartMetrics. The video file can be imported into the
program and then the image is labeled using the functions located on the left hand side of
the figure. For example, four end-diastole measurements and 3 end-systole measurements
can be set for use in determining cardiac function. As well, the epicardium, endocardium,
and truncus can be labeled. The point selection allows for marking of the endocardial and
epicardial borders. The coordinates generated from outlining the epicardial and
endocardial borders is then exported to Microsoft Excel to automatically compute cardiac
function. The embryo depicted is at stage 48, which represents a developmental period
when cardiogenesis is complete.
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Figure 6. Depictions of end-diastole using HeartMetrics. Panels A – C depict enddiastole as it would be observed on the HeartMetrics program after being processed by
the hemoglobin contrast filter. Panel A depicts a schematic of end-diastole with the
appropriate labels that would be marked using the HeartMetrics program (red crosses).
This image is at stage 48 when the aortic arches become easily distinguishable and
situated more ventrally. At this stage, gross changes in cardiac morphology have already
been completed. The black region represents the ventricular cavity whereas the grey
region represents the highly trabeculated areas and the ventricular wall. The coordinates
assigned to the labels are averaged over four heartbeats and exported to Excel where
algorithms are applied to generate measurements of cardiac function. Panel B depicts an
imaged embryo during end-diastole using HeartMetrics. A LUT transformation has been
applied to increase the contrast. The embryo represented is at stage 47 and gross
morphological movements in cardiac development are complete. The red crosses are
labeled to demonstrate the labeling function of HeartMetrics, which allows for the
outlining of the epicardial and endocardial borders. This is in accordance with the
procedure outlined for the previous panel. Panel C depicts the identical embryo as the
previous panel, except the epicardium (green) and endocardium (blue) are labeled and the
perimeters are drawn, which is another function of HeartMetrics. Legend: AA = aortic
arch; TA = truncus arteriosus; EpiB = epicardial border; EndoB = endocardial border; V
= ventricle
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Figure 7. Depictions of end-systole using HeartMetrics. End-systole is depicted in
panels A – C to demonstrate the images generated using HeartMetrics. Images are
processed using a hemoglobin contrast filter to optimize contrast. A schematic of endsystole is depicted in panel A with the corresponding labels that would be marked using
the HeartMetrics program (red crosses). The embryo is representative of stage 48 of
development, which corresponds to when the aortic arches become easily distinguishable
and situated more ventrally. At this point, gross changes in cardiac morphology are
complete. The grey region represents areas with high levels of trabeculation and the
ventricular wall. The coordinates corresponding to the red crosses are averaged over four
heartbeats. Subsequently, this data is exported to Microsoft Excel where algorithms are
applied to compute cardiac function. A HeartMetrics image frame of a stage 47 embryo is
depicted in panel B. A logarithmic LUT transformation was applied to increase the
contrast of the image. The red crosses are marked to indicate the appropriate labeling
functions that would be applied when operating the HeartMetrics program. The labeling
function is used to outline the epicardial and endocardial borders. Panel C depicts the
embryo shown previously in panel B, except the endocardium (blue) and epicardium
(green) are labeled and the perimeters are drawn, which is an additional function of
HeartMetrics. Legend: AA = aortic arch; TA = truncus arteriosus; EpiB = epicardial
border; EndoB = endocardial border; V = ventricle
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2.4 Computing Cardiac Function
As described previously, cardiac images were obtained and analyzed on HeartMetrics
then exported to Microsoft Excel for computation. An ellipsoidal model for the ventricle
shape was used to generate the measurements.
Measurements obtained for the normative sample included heart rate, stroke volume,
cardiac output, ventricular wall thickness at end-diastole, and ventricular wall thickness
at end-systole. Flow velocity was calculated for stage 48 embryos by tracing the distance
traveled by a single erythrocyte over the course of one frame.
Cardiac parameters gathered for embryos treated with small molecules did not include
functional examination at end-systole as discussed in a later section. Parameters were
measured at end-diastole and included cross-sectional area of the ventricular cavity
(CSAV), volume of blood in the ventricular cavity (VV), and ventricular wall thickness
(VWT). Heart rate was also compared for each of the treatment groups.

2.4.1

Heart Rate

Heart rate (HR) was calculated by averaging the frames elapsed from end-diastole until
the successive end-diastole (Refer to Figure 5). The computation also accounts for the
pre-set frame rate of the system, which is 318.2 fps. Heart rate is represented as beats per
minute (bpm).
AF (frames) = [(ED2 – ED1) + (ED3 – ED2) + (ED4 – ED3)] / 3
HPS = 318.2fps / AF
HR (bpm) = HPS x 60
Legend: AF = average number of frames elapsed during one heart beat; ED = frame
number at end-diastole; HPS = heart beats per second; HR = heart rate; fps = frames per
second; bpm = beats per minute
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2.4.2

Ventricular Wall Thickness

Ventricular wall thickness (VWT) was measured at either end-diastole or end-systole.
The computation of these measurements utilizes the labels that were added to the
HeartMetrics program that marked the endocardial and epicardial borders at three enddiastoles and three end-systoles (Refer to Figures 6 and 7). Labeling of points in
HeartMetrics allowed for the generation of coordinates along the epicardial and
endocardial borders that were subsequently used to calculate the diastolic and systolic
ventricular wall thickness pairs. All calculations were averaged for seven measurements
for each ventricular border. Measurements are computed in millimeters (mm).
DVWTP1 (mm) = | DL1 – D2 |
DVWTP2 (mm) = | D3 – D4 |
DVWTP3 (mm) = | DW5 – D6 |
DVWTP4 (mm) = | D7 – D8 |
DVWTP5 (mm) = | D9 – D10|
DVWTP6 (mm) = | DW11 – D12 |
DVWTP7 (mm) = | D13 – D14 |
VWTD (mm) = ( DVWTP1 + DVWTP2 + DVWTP3 + DVWTP4
+ DVWTP5 + DVWTP6 +DVWTP7 ) / 7
Legend: DVWTP = Diastolic ventricular wall thickness pair; VWTD = average
ventricular wall thickness (end-diastole); mm = millimeters
SVWTP1 (mm) = | SL1 – S2 |
SVWTP2 (mm) = | S3 – S4 |
SVWTP3 (mm) = | SW5 – S6 |
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SVWTP4 (mm) = | S7 – S8 |
SVWTP5 (mm) = | S9 – S10 |
SVWTP6 (mm) = | SW11 – S12 |
SVWTP7 (mm) = | S13 – S14 |
VWTS = ( SVWTP1 + SVWTP2 + SVWTP3 + SVWTP4
+ SVWTP5 + SVWTP6 + SVWTP7 ) / 7
Legend: SVWTP = Systolic ventricular wall thickness pair; VWTS = average ventricular
wall thickness (end-systole); mm = millimeters

2.4.3

Stroke Volume & Volume of Blood in the Ventricular Cavity
at End-Diastole

Stroke volume (SV) is considered equivalent to the volume of blood in the ventricular
cavity (VV) at end-diastole for the normative sample in this project because
approximately 100% ejection fraction was observed. Stroke volume is the volume of
blood pumped by the heart for one cardiac contraction and if no blood is present in the
ventricle at end-systole then the entire volume of blood at end-diastole was pumped
during the single contraction. Stroke volume is considered synonymous to diastolic traced
ventricular ellipsoidal volume (DTVEV) in the HeartMetrics program. Labeling of the
endocardium at end-diastole in HeartMetrics is required for computing stroke volume
(Refer to Figure 6). The points labeled in HeartMetrics along the endocardial border
during end-diastole were used to generate the ventricular lengths. The value is averaged
over four end-diastoles and represented in microliters (µL).
DVL (mm) = | DL0 – DL1 |
DVED2 (mm) = | DW5 – DW11 |
DTVEV (mm3) = SV = 4/3 x π x DVL x DVED22
DTVEVav (mm3) = SVav = ( DTVEV1 + DTVEV2 + DTVEV3 + DTVEV4 ) / 4
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DTVEVav (µL) = SVav = DTVEVav (mm3) / 1000 x 1000
Legend: DVL = diastolic ventricular length; DVED = Diastolic ventricular end
dimension; DTVEV = diastolic traced ventricular ellipsoidal volume; SV = stroke
volume; DTVEVav = average diastolic traced ventricular ellipsoidal volume; SVav =
average stroke volume; mm = millimeters; µL = microliters

2.4.4

Cross-sectional Area of the Ventricular Cavity

Cross-sectional area of the ventricular cavity (CSAV) represents the 2D region of the
ventricular cavity that is occupied by erythrocytes at end-diastole. CSAV can be
computed in a similar manner to stroke volume, except it is calculated in two dimensions
instead of three dimensions. Therefore, the units are represented as an area in
millimeters2 (mm2) as opposed to a volume. This calculation requires the labeling of the
endocardial border at end-diastole in the HeartMetrics program (Refer to Figure 6). The
coordinates generated by labeling points in HeartMetrics along the endocardial border at
end-diastole were used to compute the ventricular lengths.
DVL (mm) = | DL0 – DL1 |
DVED2 (mm) = | DW5 – DW11 |
CSAV (mm2) = π x DVL x DVED2
CSAVav (mm2) = ( CSAV1 + CSAV2 + CSAV3 + CSAV4 ) / 4
Legend: DVL = diastolic ventricular length; DVED = Diastolic ventricular end
dimension; mm = millimeters; CSAV = cross-sectional area of the ventricular cavity;
CSAVav = average cross-sectional area of the ventricular cavity

2.4.5

Cardiac Output

Cardiac output (CO) represents the volume of blood ejected from the heart per minute
and is measured in microliters/minute (µL/min). Cardiac output can be calculated by
simply multiplying the stroke volume by the heart rate.
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CO (µL/min) = SV (µL) x HR (bpm)
Legend: CO = cardiac output; µL = microliters; min = minutes; SV = stroke volume; HR
= heart rate; bpm = beats per minute

2.4.6

Flow Velocity

Flow velocity (FV) was not computed using the pre-programmed HeartMetrics
algorithms, but was calculated separately using cell labeling on HeartMetrics (Refer to
Figure 5) (Movie 5). This parameter involved computing the distance in millimeters that
was traveled by a single erythrocyte in one frame. The x- and y-coordinates of the
erythrocyte were provided after the data was exported to Microsoft Excel. Subsequently,
the distance traveled was calculated as the hypotenuse by using the Pythagorean Theorem
and the x- and y- coordinates generated by HeartMetrics. Depending on the calibration
used, the HeartMetrics program allowed me to identify the value of pixels in 1
millimeter. Furthermore, the user is aware of the frame rate of the captured video, which
was 318.2 fps in these experiments. Flow velocity was then averaged over four separate
measurements and assigned units of millimeters/second (mm/s). The data was gathered
directly after end-diastole during ventricular contraction. During this interval, cardiac
contraction and velocity of erythrocytes are at a relative maximum.
DTP (pixels) = ( | X1 – X2 | 2 + | Y1 – Y2 | 2 )1/2
DTM (mm) = DTP / CU
DTav (mm) = ( DTM1 + DTM2 + DTM3 + DTM4 ) / 4
FV (mm/s) = DTav x 318.2 fps
Legend: DTP = distance traveled in pixels; X1 = x-coordinate of erythrocyte in first
frame; X2 = x-coordinate of erythrocyte in second frame; Y1 = y-coordinate of
erythrocyte in first frame; Y2 = y-coordinate of erythrocyte in second frame; DTM =
distance traveled in millimeters; mm = millimeters; CU = calibration unit (number of
pixels in one millimeter); DTav = average distance travelled; FV = flow velocity; s =
seconds; fps = frames per second
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2.5 Xenopus Treatments
2.5.1

Known Modulators of Heart Rate

Xenopus laevis embryos were exposed to classical modulators of heart rate at various
stages depending on the nature of the experiment. The embryos were exposed to the
modulators at stage 37/38 to stage 45 to determine the developmental interval in which
cardiac response to pharmacological agents originates. For the heart rate studies, classical
modulators were applied once embryos matured to stages 46-48.
Three of the modulators used are known to increase heart rate in Xenopus: atropine
(Sigma), (-)-epinephrine (Sigma), and (-)-isoproterenol hydrochloride (Sigma) (Shutt and
Bowes, 1979; Callaway, 2013; Cirić and Susić, 1980). An individual embryo was
submerged in the solution for 3 minutes before being removed and embedded in 0.8%
LMP agarose. Subsequently, cardiac images were acquired and used to measure heart rate
in beats per minute. The embryos were subjected to increasing concentrations of atropine,
including: 0mg/mL (distilled H2O) [0mM], 0.05mg/mL [0.17mM], 0.1mg/mL [0.35mM],
0.5mg/mL [1.73mM], and 1mg/mL [3.46mM]. The concentrations of epinephrine
included: 0mg/mL (distilled H20) [0mM], 0.05mg/mL [0.27mM], 0.1mg/mL [0.55mM],
0.5mg/mL [2.73mM], and 1mg/mL [5.46mM]. The increasing concentrations of
isoproterenol included: 0mg/mL (distilled H20) [0mM], 0.05mg/mL [0.20mM],
0.1mg/mL [0.40mM], 0.5mg/mL [2.02mM], and 1mg/mL [4.04mM]. Concentrations
were obtained by dissolving the pharmacological agent in distilled water.
The pharmacological agent (±)-metoprolol (+)-tartrate salt (Sigma) has been shown in the
literature to decrease heart rate, therefore metoprolol was used in this study to contrast
the other classical modulators (Fujito et al., 2014). The procedure for this
pharmacological agent was similar to the procedure outlined above for the other drugs,
except that the concentrations used included: 0mg/mL (distilled H20) [0mM], 0.5mg/mL
[0.73mM], 1mg/mL [1.46mM], 5mg/mL [7.30mM], and 10mg/mL [14.60mM].
An experiment involving the combination of atropine and metoprolol was performed.
Initially, embryos were submerged in 0mg/mL (distilled H20) to obtain baseline
measurements of heart rate. Next, the embryo was submerged in successively increasing
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concentrations of atropine (0.05mg/mL, 0.1mg/mL, and 1mg/mL). Afterwards, embryos
were immersed in solutions with successively increasing concentrations of metoprolol
that were dissolved in a 1:1 ratio with 1mg/mL of atropine (0.5mg/mL, 1mg/mL,
10mg/mL).
Concentration 1: 0mg/mL of drug
Concentration 2: 0.05mg/mL atropine
Concentration 3: 0.1mg/mL atropine
Concentration 4: 1mg/mL atropine
Concentration 5: 1mg/mL atropine + 0.5mg/mL metoprolol
Concentration 6: 1mg/mL atropine + 1mg/mL metoprolol
Concentration 7: 1mg/mL atropine + 10mg/mL metoprolol
Heart rate was determined using the equation outlined previously and measured in beats
per minute.

2.5.2

Small Molecule Treatments on Embryos

Xenopus laevis embryos were submerged in treatments at various stages including stages
8.5, 14, 26, and 33/34 depending on the experiment. The concentrations of the treatments
included 100µM (-)-blebbistatin (Calbiochem), 100µM (+)-blebbistatin (Calbiochem),
20µM Rockout (EMD), 1µM retinoic acid (RA) (Sigma), and 1µM retinoic acid receptor
antagonist (RAA; also known as AGN193109) (Allergan #193109) (Agarwal et al.,
1996). Concentrations used were chosen based on experiments previously performed by
members of the lab that demonstrated defects in cardiac morphology through in situ
hybridizations (Collop et al., 2006; Halabi, 2013).
Every small molecule, except for ethanol, was dissolved in dimethylsulfoxide (DMSO)
(Fisher Scientific) and then brought to working concentration using 20% Steinberg’s
solution. DMSO was used as the vehicle control for each experiment, except for the
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ethanol experiment. The concentration of DMSO was 1µL/mL for the Rockout and
retinoic acid experiments, whereas the concentration of DMSO for the blebbistatin
experiment was 10µL/mL. (+)-blebbistatin is an inactive enantiomer and served as
another control for the specificity of (-)-blebbistatin activity.
Embryos were removed from their respective treatments after 24 hours at room
temperature, except for the ethanol experiments. Afterwards, embryos were submerged in
20% Steinberg’s solution following several washes. Cardiac images were captured once
embryos matured to stage 46 and onwards. After video imaging as described above,
embryos were fixed in MEMPFA (4% Paraformaldehyde dissolved in distilled H2O,
1mM MgSO4, 100mM Mops pH 7.5, 2mM EGTA pH 8.0) at room temperature for 2
hours or for 16 hours at 4°C in preparation for whole mount in situ hybridization.
Embryos were then dehydrated in cold 100% methanol for storage at 4°C.
The procedure for the ethanol experiments was slightly modified from the protocol
outlined above for the other small molecules. The embryos were either exposed to 20%
Steinberg’s solution or 1.5% ethanol (Fisher Scientific) dissolved in 20% Steinberg’s
solution. Xenopus embryos were maintained in the treatment until the time of imaging at
stage 46 and onwards. The solution was replaced at least every 24 hours due to the
volatility of ethanol.

2.6 Whole Mount In Situ Hybridization
The whole mount in situ hybridization protocol was based on Deimling et al. (Deimling
et al., 2015). Xenopus embryos were submerged in potassium chloride prior to fixation to
permit collection of morphology parameters following cardiac arrest at end-diastole.
BM Purple (Roche) was used for the colourometric reaction. Antisense probes against
cTnI mRNA were used to specifically label the myocardium (Drysdale et al., 1994;
Kolker et al., 2000; Lohr and Yost, 2000; Mohun et al., 2000). Embryos were fixed for an
additional 20 minutes in MEMPFA to create a permanent stain. Subsequently, the
embryos were bleached using bleaching solution (1% H2O2, 50% formamide, and 0.5%
SSC) to increase the contrast of the probe-labeled regions by removing the endogenous
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pigmentation. Bleaching was performed for 16 hours at 4°C or 3 hours at approximately
25°C.
Individual images of each embryo were collected using Northern Eclipse (Empix
Imaging; Mississauga, ON, Canada) with the Leica MZ12 and DFC450 camera.

2.7 Cardiac Morphology Measurements
Measuring cardiac morphology for treatment groups involved examining the in situ
hybridization images. Images acquired were further analyzed using straight-line and
curved functions of Northern Eclipse. Measurements of the ventricle included
longitudinal length (LL), transverse length (TL), perimeter (P), and cross-sectional area
(CSA).

2.8 Origin of Cardiac Response
Transgenic Nkx2.5-GFP embryos were generated using the same methods described
above and embryos were allowed to mature until stages 37-39 before imaging. In
contrast, wild-type embryos were used after maturing to stages 40-45. Embryos were then
embedded in 0.8% LMP agarose and visualized under the Leica M205 FA stereoscope.
The origin of cardiac response in my experiments is defined as the initial developmental
interval in Xenopus where the heart is first able to display autonomic responses following
exposure to pharmacological agents (Armour, 1999).
The fluorescent feature of the stereoscope allowed for the heart to be visualized for
embryos ranging from stages 37 to 39, which is ordinarily challenging due to the natural
pigmentation of the embryo. The time elapsed for 10 heartbeats was measured and used
later for computation of heart rate. The heart rate was averaged for three separate
measurements due to the variability of the method. Subsequently, embryos were exposed
to 1mg/mL of isoproterenol for 3 minutes preceding imaging. The identical procedure
was performed as stated above to determine heart rate. Heart rate was determined in beats
per minute (bpm).
T10,av (s) = ( T10,1 + T10,2 + T10,3 ) / 3
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T1 (s) = T10,av / 10
HR (bpm) = 60 / T1
Legend: T10 = time elapsed for 10 heartbeats; T10,av = average time elapsed for 10
heartbeats; T1 = time elapsed for one heartbeat; s = seconds; HR = heart rate; bpm = beats
per minute
Conversely, wild-type embryos that had matured to stages 40-45 were collected and
baseline heart rates were measured after immersing the embryo in H2O for 3 minutes.
Videos were collected using the Flare camera and later analyzed using HeartMetrics to
measure the heart rate averaged over 4 heartbeats. Afterwards, embryos were submerged
in 1mg/mL of isoproterenol for an additional 3 minutes preceding imaging. Heart rate
was measured using the equation outlined previously and stated in beats per minute.

2.9 Statistical Analyses
All statistical analyses were performed on GraphPad Prism 6.0 software.

2.9.1

Normative Sample

Xenopus laevis embryos that ranged from stages 45 to 48 were used to represent the
normative sample. The results obtained from these embryos were analyzed using a oneway ANOVA paired with a Tukey’s post-hoc test. Significance was represented by pvalues less than 0.05.

2.9.2

Classical Modulators of Heart Rate

Dose-response experiments included data using atropine, epinephrine, isoproterenol, and
metoprolol. Data was analyzed using a non-linear fit regression where the x- and y-axes
were represented as linear.

2.9.3

Comparison of Cardiac Function & Morphology Following
Disruption of Cardiogenesis

Cardiac function and morphology were analyzed using a two-way ANOVA paired with a
Sidak test. This included analysis of embryos treated with RA and RAA, (-)-blebbistatin,
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Rockout, and ethanol. Each data set was compared to individual control groups
containing genetically identical offspring. Significance was represented by p-values less
than 0.05.
Heart rate was also measured for each treatment and analyzed using a two-way ANOVA
paired with a Sidak test. Significance was represented by p-values less than 0.05.

2.9.4

Origin of Cardiac Response

The cardiac response data was analyzed using a non-linear fit regression. Both the x- and
y-axes were treated as linear.
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Chapter 3

3

Results

Note: All supplementary movies are shown at a frame rate of 30 fps instead of the
original 318 fps to avoid playback errors experienced by some media players. The heart
can be identified by the beating tissue located in the center of the image with the pixels
cycling between dark and light, which corresponds to the cardiac cycle.

3.1 Establishing Normal Cardiac Function Parameters for
Xenopus embryos
In order to evaluate our video imaging system’s ability to measure cardiac function in
Xenopus, functional data was collected for a normative sample of Xenopus embryos that
could be used to compare to previous methods. In addition, some of the functional
assessments we performed have not, to our knowledge, been previously documented for
Xenopus, therefore, our results will expand our knowledge of early cardiogenesis in this
model organism.
The video imaging system provided the ability to study embryos at four developmental
stages during which cardiogenesis is considered relatively complete (Kolker et al., 2000).
The stages assessed included stages 45, 46, 47, and 48 (Movies 1, 2, 3, and 4,
respectively). A sample size of fifty embryos was used to characterize each stage when
assessing functional data. The embryos were not studied longitudinally, so each stage is
considered to be a separate non-identical subset. Although I attempted to assess embryos
earlier than stage 45 and later than stage 48, there were optical considerations that created
more difficulty and less accuracy in measuring function. Embryos earlier than stage 45
were difficult to assess due to decreased hemodynamics and increased pigmentation, as
well as increased opacity on the ventral ectoderm. Embryos older than early stage 48
were considerably larger than younger embryos creating an increased working distance
that decreased the sharpness of the epicardial and endocardial contours. This will be
explained more thoroughly in a section addressing limitations of this system.
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3.1.1

Ejection Fraction

A previous study (Deniz et al., 2012) concluded, after utilizing hemoglobin contrast
subtraction angiography, that Xenopus tropicalis, a closely related species, ordinarily
have 100% ejection fraction thereby completely emptying the ventricle of blood by endsystole. Images captured using our system corroborate this finding (for an example, refer
to Movie 1). Therefore, in my experiments I assumed approximately 100% ejection
fraction such that blood volume in the ventricle at end-systole is negligible in comparison
to ventricular volume at end-diastole.

3.1.2

Heart Rate

The heart rate of 50 separate embryos at each stage was obtained and used to compare the
four developmental intervals (Figure 8). The mean heart rate at stage 45 was observed to
be 91.7bpm, whereas the average heart rate was calculated to be 124.6bpm by stage 46.
The mean computed at stage 47 was 139.3bpm and the average heart rate at stage 48 was
144.2bpm. Overall, heart rate increased significantly as the embryo developed from stage
45 through to stage 47, although there was no significant increase in heart rate from stage
47 to 48. I noted that heart rate varies considerably in this species as compared to other
animal models. In addition, the most dramatic increase appears to be following
maturation of stage 45 embryos to stage 46.
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Figure 8. Heart rate increases in Xenopus laevis embryos from stages 45 to 48. The
average heart rate of Xenopus laevis embryos was analyzed at four stages of cardiac
development. There were significant increases in heart rate from stage 45 through to
stage 47, although no significant difference was observed between stages 47 and 48. A
one-way ANOVA paired with a Tukey’s post-hoc test was used to compare the heart rate
data. The means are indicated by the center of the red bars and the end bars represent
±SEM. n = 50 for each group; **p ≤ 0.01; ****p ≤ 0.0001
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3.1.3

Ventricular Wall Thickness

Ventricular wall thickness (VWT) was measured at both end-diastole and end-systole at
stages 45 to 48 (Figure 9).
Significant increases in ventricular wall thickness at end-diastole were observed (Figure
9A). The mean at stage 45 was determined to be 4.95 x 10-2mm. An increase in thickness
was observed by stage 46 with an average calculated to be 6.03 x 10-2mm. The mean
computed at stage 47 was 6.68 x 10-2mm, whereas the average VWT by stage 48 was
7.40 x 10-2mm. A significant increase in ventricular wall thickness at end-diastole was
shown when comparing every stage examined.
Additionally, VWT at end-systole was also examined (Figure 9B). The mean ventricular
wall thickness at end-systole for stage 45 was 9.29 x 10-2mm. At stage 46, the mean
VWT was 9.71 x10-2mm, whereas the average was 1.19 x 10-1mm for stage 47. Embryos
at stage 48 had an average ventricular wall thickness of 1.25 x 10-1mm at end-systole. A
significant increase in VWT was observed when comparing stage 45 to either stage 47 or
48. A significant increase was also detected between stage 46 and the two later stages.
There was no significant difference between stages 45 and 46 and no significant increase
was observed between stages 47 and 48.
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Figure 9. Average ventricular wall thickness of Xenopus laevis embryos increases
from stages 45 to 48. The average ventricular wall thickness (VWT) at end-diastole was
analyzed at stages 45, 46, 47, and 48 (Panel A). An increase in VWT was observed as
embryos matured through the four stages. A significant difference was determined
between all groups that were analyzed. As well, the average ventricular wall thickness
was also examined at end-systole (Panel B). No significant differences were observed
following comparison of stage 45 and stage 46 as well as no significant increase between
stages 47 and 48. However, increases in VWT were observed when comparing stage 45
to stages 47 and 48 or through comparison of stage 46 and the two later developmental
stages. Analysis of the data involved a one-way ANOVA paired with a Tukey’s post-hoc
test. The end bars represent ±SEM. n = 50 for each group; *p ≤ 0.05; ***p ≤ 0.001;
****p ≤ 0.0001
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3.1.4

Stroke Volume and Cardiac Output

Another parameter that was analyzed to determine cardiac function in early Xenopus
embryos was stroke volume (SV) (Figure 10A). Stroke volume represents the volume of
blood that is pumped by the heart for a single cardiac contraction. A collective 200
embryos were measured spanning four developmental stages. Importantly, ejection
fraction was assumed to be approximately 100% implying that the blood volume in the
ventricular cavity at end-systole was approximately zero. This is based on both previous
observations and our own video images (Deniz et al., 2012) (Movie 1). Significant
increases in stroke volume were observed when stages 45 or 46 were compared to stages
47 and 48. Embryos at stages 45 and 46 were not statistically different and no significant
difference was observed when comparing stages 47 and 48. The mean stroke volume at
stage 45 and 46 was 1.2 x 10-3µL and 1.8 x 10-3µL, respectively. The mean computed at
stage 47 was 3.8 x 10-3µL and the mean SV for stage 48 embryos was calculated to be 3.9
x 10-3µL.
Cardiac output (CO) was measured for Xenopus embryos during stages 45, 46, 47, and 48
(Figure 10B). Cardiac output represents the volume of blood pumped by the heart in a
minute and is dependent on stroke volume and heart rate. There was an overall increase
in CO observed as the embryos progressed through the stages. The average CO for stage
45 was 1.2 x 10-1µL/min. For stage 46 embryos, the average cardiac output was
calculated to be 2.3 x 10-1µL/min, whereas the mean for stage 47 embryos was
5.3 x 10-1µL/min. The mean cardiac output computed for stage 48 was determined to be
5.7 x 10-1µL/min. A significant increase in CO was observed following comparison of
stage 45 embryos and every other stage. A functionally significant increase was observed
following comparison of stage 46 with the two most mature stages. The only stages that
were not statistically different following comparison were stages 47 and 48.
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Figure 10. Average stroke volume and cardiac output increases between stages 45
and 48 in Xenopus laevis embryos. The average stroke volume was determined from
embryos spanning stages 45 to 48 (Panel A). No statistical differences were observed
between the two earlier stages as well as between the two later stages. However, a
statistically significant increase was detected between stage 45 embryos and the two most
mature stages. A statistical increase was demonstrated between stage 46 and the two later
stages. Furthermore, cardiac output was assessed for the four developmental stages
(Panel B). A statistically significant difference was observed following comparison of
stage 45 embryos with every other stage. Stage 46 embryos were also identified as being
significantly different from every other stage for cardiac output. There was no significant
difference when comparing stage 47 against stage 48. A one way-ANOVA paired with a
Tukey’s post-hoc test was used to compare the stages. The end bars represent ±SEM. n =
50 for each group; *p ≤ 0.05; ****p ≤ 0.0001
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3.1.5

Flow Velocity

Flow velocity (FV) was computed through the use of the HeartMetrics software. This
parameter involved tracking the velocity of individual erythrocytes in the anterior portion
of the left aortic arch directly after end-diastole when cardiac contraction was at a
maximum. The embryos used in the normative sample to measure cardiac function were
not the identical embryos used for this experiment. This experiment involved the
measurement of laminar flow within the center of the vessel, as turbulent flow along the
vessel walls could not be measured using the method selected.
The flow velocity was measured for fourteen embryos that were morphologically normal
(Figure 11; Movie 5). Xenopus embryos were at stage 48 at the time of imaging. The
average flow velocity was determined to be 4.0mm/s, however, considerable variability
in the measurements was observed.

3.1.6

Conclusions

The video imaging system was able to assess cardiac function between stages 45 and 48
in Xenopus laevis development. We found small, but significant increases in heart rate
and cardiac function as embryos matured.
However, in order to further verify the ability of this system to detect changes in cardiac
function in Xenopus, we proposed to use pharmacological agents that have welldocumented effects on heart rate.
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Figure 11. Flow velocity in the left aortic arch of stage 48 Xenopus embryos. The
figure depicts the individual flow velocities of fourteen separate stage 48 Xenopus laevis
embryos. Each measurement was performed four times and averaged to provide
representative data. To perform the experiment, individual erythrocytes were tracked in
the anterior portion of the left aortic arch directly after end-diastole. The average flow
velocity was determined to be 4.0mm/s with a standard error of mean of 2.0mm/s. n = 14
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3.2 Classical Modulators of Heart Rate
3.2.1

Rationale

The sino-atrial node (SAN) is the cardiac region that acts as the pacemaker of the heart
(Tripathi et al., 2001). The spontaneous electrical activity generated by the SAN normally
serves as the origin of the organism’s heart rate and rhythmicity. The rate and rhythmicity
of the heart can be manipulated using various pharmacological agents.
The effect that these pharmacological agents have on heart rate is well documented, so
the outcomes following administration of these drugs to Xenopus laevis embryos are
predictable. Therefore, exposure of Xenopus embryos to these pharmacological agents
can be used to determine if we can assess changes in cardiac function using our system.
To modify heart rate, we chose to use atropine, epinephrine, isoproterenol, and
metoprolol. The Xenopus laevis embryos used in these experiments ranged from stages
46 to 48 because we could test function at these stages. We were able to demonstrate
predictable changes in heart rate using our imaging system.

3.2.2

Atropine, Epinephrine, and Isoproterenol

Atropine is recognized to act as an antagonist for the acetylcholine receptors located in
the parasympathetic nervous system (Shutt and Bowes, 1979). Exposure to atropine
causes tachycardia or an increase in heart rate. Based on the experiment performed,
atropine increased heart rate in an expected manner (Figure 12A). The highest
concentration resulted in a 21.5% increase in heart rate compared to the basal heart rate.
Maximal sensitivity to atropine appears to start at approximately 0.05mM-0.1mM
(concentrations 2 and 3) and the response shows saturation following administration of
higher doses.
Epinephrine, otherwise referred to as adrenaline, is a hormone endogenous to the human
body. Exogenous administration of epinephrine has been cited in the literature to increase
heart rate (Callaway, 2013). We observed a concentration-dependent increase in heart
rate in Xenopus embryos following epinephrine exposure (Figure 12B). Heart rate was
increased by 20.5% compared to baseline at the highest concentration of epinephrine.

56

Isoproterenol exerts its pharmacological effects by serving as a beta-adrenergic agonist
and has commonly been referred to as isoprenaline. Isoproterenol administration has been
shown to induce increases in heart rate (Cirić and Susić, 1980). Following exposure to
increasing concentrations of isoproterenol, an increase in heart rate was observed for
Xenopus embryos (Figure 12C). The highest concentration of isoproterenol produced a
20.1% increase in heart rate compared to baseline measurements. Maximal sensitivity to
isoproterenol appears to be attained at concentration 3 (0.1mM), therefore, concentrations
4 and 5 show a plateau signifying saturation.
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Figure 12. Atropine, epinephrine, and isoproterenol exposure result in increases in
heart rate for Xenopus embryos. Xenopus laevis embryos were subjected to various
concentrations of atropine (Panel A), epinephrine (Panel B), and isoproterenol (Panel C)
to examine whether the expected increase in heart rate could be detected using our
imaging system. Xenopus embryos had matured to stages 46-48 prior to assessment. The
data demonstrates a positive correlation between concentration of drug and heart rate for
each pharmacological agent studied. A non-linear regression was used to analyze the data
and both axes are shown as linear. The end bars represent ±SEM. n = 7, 7, and 6 for the
atropine, epinephrine, and isoproterenol experiments, respectively; bpm = beats per
minute
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3.2.3

Metoprolol and Drug Combinations

In contrast, metoprolol is a β-blocking agent that is clinically used to treat tachycardia
(Fujito et al., 2014). Therefore, the pharmacological properties of metoprolol culminate
in a decrease in heart rate after administration. As predicted, metoprolol exposure
resulted in a reduction in heart rate in a concentration-dependent manner (Figure 13A).
Acute metoprolol exposure resulted in a 57.3% reduction in heart rate at the highest
concentration in comparison to baseline heart rate.
Next, a combination of atropine and metoprolol was used to observe the antagonistic
effects that these pharmacological agents have on heart rate (Figure 13B). To accomplish
this, a baseline measurement of heart rate was measured and is represented as
concentration 1 in the figure. Subsequently, Xenopus embryos were exposed to increasing
concentrations of atropine, therefore, an initial increase in heart rate was expected. This
was confirmed by an increase in heart rate during exposure to concentrations 2, 3 and 4.
Afterwards, increasing concentrations of metoprolol were mixed with 1mg/mL of
atropine. This resulted in a dose-dependent reduction in heart rate from concentrations 5
to 7. The heart rate is shown below baseline measurements at the highest concentration of
metoprolol.

3.2.4

Conclusions

Our imaging system appears to be capable of detecting heart rate changes accurately. In
addition, we can conclude that Xenopus embryos respond to classical heart rate
modulators as expected when treated between stages 46-48.
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Figure 13. Xenopus embryos exposed to metoprolol and atropine demonstrated the
expected changes in heart rate. Exposure of Xenopus laevis embryos to metoprolol was
documented to observe whether decreases in heart rate could be detected (Panel A). The
data indicates that increasing concentrations of metoprolol caused a subsequent reduction
in heart rate. Analysis of heart rate utilized a non-linear regression with both axes
depicted as linear. Conversely, Xenopus laevis embryos were exposed to a combination
of atropine and metoprolol to observe the antagonistic effects that these pharmacological
agents have on heart rate (Panel B). Initially, heart rate was measured before any
pharmacological agents were used (orange arrow). Subsequently, embryos were exposed
to increasing concentrations of atropine and an increase in heart rate was observed. Next,
increasing concentrations of metoprolol were added to 1mg/mL of atropine and a
concentration-dependent decrease in heart rate was observed. A non-linear regression
was used to assess the data and both axes were represented as linear. The end bars
represent ±SEM. n = 7 and 8 for the metoprolol and combination experiments,
respectively; bpm = beats per minute; A = atropine; M = metoprolol
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3.3 Functional Changes Due to Morphological Alterations
The previous experiments focused on embryos that were allowed to develop normally.
However, my overall objective was to test if we could see changes in cardiac function in
embryos with morphological defects. We would predict that embryos with such defects
would have significant alterations in cardiac function. To our knowledge, using this novel
imaging system would be the first time that changes in cardiac function are analyzed in
Xenopus embryos with known morphological changes.

3.3.1

Blebbistatin and Rockout

As mentioned previously, blebbistatin acts as an inhibitor of non-muscle myosin II,
which acts downstream of ROCK signaling (Allingham et al., 2005; Amano et al., 1996;
Dou et al., 2007; Swift et al., 2012). Experiments performed by Halabi demonstrated that
exposure of Xenopus laevis embryo to (-)-blebbistatin initiating at stage 26 resulted in the
disappearance of flexion points in the closing heart tube at stage 31/32. The absence of
flexion points signifies disruption of proper cardiac tube closure. This was demonstrated
through in situ hybridization using antisense mRNA probes against cardiac troponin I to
selectively stain the myocardium (Halabi, 2013).
To further demonstrate that the changes were due to inhibition of ROCK signaling, we
exposed embryos to Rockout, a second ROCK inhibitor. Rockout inhibits the ability of
ROCK-II to phosphorylate MLC, thereby inhibiting ROCK activity, as is the case with
blebbistatin. In situ hybridizations performed by Halabi demonstrated that Rockout
disrupts cardiogenesis if Xenopus embryos are exposed starting at stage 26. As with the
blebbistatin treatment, the flexion points did not develop properly as expected (Halabi,
2013).
Embryonic treatments were performed at stages 26 and 33/34 to observe cardiac
disruptions resulting from ROCK inhibition. For the blebbistatin treatment, Xenopus
embryos were either immersed in DMSO, (+)-blebbistatin, or (-)-blebbistatin, in which
both DMSO and (+)-blebbistatin acted as control groups. For the Rockout treatment,
embryos were either exposed to DMSO or Rockout. Embryos were exposed to the
respective treatment for 24 hours at room temperature before being transferred to 20%
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Steinberg’s solution. Embryos were maintained until maturing to stage 46 and onwards
prior to cardiac imaging and subsequent fixation for in situ hybridization.
Based on HeartMetrics images, there does appear to be a defect in cardiac looping for
embryos exposed to (-)-blebbistatin when treated at both developmental periods. For my
experiments, in situ hybridization for cardiac troponin I expression was used to
selectively stain the myocardium for blebbistatin-exposed embryos (Figure 14A) and
Rockout-exposed embryos (Figure 14B). In contrast to the data provided following
blebbistatin exposure, there did not appear to be gross cardiac looping defects for
Rockout-exposed embryos.
Heart rate was measured to identify potential variations in heart rate following exposure
to blebbistatin (Figure 15A). A statistical increase in heart rate was only confirmed for
embryos exposed to (-)-blebbistatin at stage 26, but not at stage 33/34. For the Rockout
treatment, heart rate was also measured to examine the effect of Rockout on heart rate
(Figure 15B). Rockout was determined to have no statistically significant effect on heart
rate at either of the treatment stages.
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Figure 14. Abnormal cardiac morphogenesis in Xenopus laevis embryos following
exposure to blebbistatin and Rockout. Following embryo fixation, the myocardium
was selectively stained through in situ hybridization using an antisense mRNA probe
against cardiac troponin I mRNA. Xenopus laevis embryos were exposed to DMSO, (+)blebbistatin, or (-)-blebbistatin commencing at stage 26 or 33/34 (Panel A). Both the
DMSO- and (+)-blebbistatin-exposed embryos served as control groups. Significant
reductions in ventricular morphology were observed in the (-)-blebbistatin-exposed
embryos following treatment at stage 26. No significant alterations in ventricular
morphology were noted following exposure at stage 33/34. As well, Xenopus laevis
embryos were exposed to either DMSO or Rockout initiating at stages 26 and 33/34
(Panel B). The ventricular dimensions of embryos treated at stage 26 with Rockout
demonstrated significant reductions. A significant increase in area of the ventricle was
noted following Rockout exposure at stage 33/34.
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Figure 15. Increase in heart rate of Xenopus embryos following exposure to
blebbistatin, but not following exposure to Rockout. Heart rate was measured and
analyzed following exposure to either DMSO, (+)-blebbistatin, or (-)-blebbistatin (Panel
A). No significant differences were observed for heart rate following exposure at stage
33/34. A significant increase in heart rate was detected following exposure to (-)blebbistatin at stage 26 compared to both of the control groups. Comparison of heart rate
for DMSO- and Rockout-exposed embryos is shown in panel B. No significant
differences in heart rate were observed following exposure to Rockout at either stage
examined. Heart rate was measured in beats per minute (bpm) and data analysis involved
a two-way ANOVA paired with a Sidak test. The end bars represent ±SEM. n = 6 for
each group; *p ≤ 0.05; ****p ≤ 0.0001
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3.3.1.1

Treatment of Xenopus laevis embryos at stage 26 with
blebbistatin and Rockout

Xenopus laevis embryos were exposed to either DMSO, (+)-blebbistatin, or (-)blebbistatin (Movie 6) initiating at stage 26. This coincides with the developmental time
point directly before cardiac differentiation and during closure of the linear heart tube
(Kolker et al., 2000; Lohr and Yost, 2000; Mohun et al., 2000).
As predicted, the embryos treated with DMSO and (+)-blebbistatin did not differ with
respect to cardiac function (Figure 16A). In contrast, statistically significant reductions in
cross-sectional area of the ventricular cavity and ventricular wall thickness were observed
for the (-)-blebbistatin-treated embryos compared to both control groups. No significant
difference was observed between any of the groups when examining volume of blood in
the ventricular cavity.
For the Rockout treatment, Xenopus laevis embryos were exposed at stage 26 to either
DMSO or Rockout (Movie 7). Based on the cardiac function analysis at end-diastole, a
significant decrease in ventricular wall thickness was detected in the Rockout-exposed
embryos (Figure 16B). Cross-sectional area of the ventricular cavity and volume of blood
in the ventricular cavity were not significantly different.
Subsequently, the embryos underwent in situ hybridization using an antisense mRNA
probe against cardiac troponin I to examine whether morphological changes could be
detected following disruption of cardiogenesis. Statistically significant decreases were
observed for transverse length, perimeter, and cross-sectional area of the ventricle for
embryos exposed to (-)-blebbistatin (Figure 17A). Significant differences were not
detected with respect to longitudinal length of the ventricle when comparing all three
groups. As predicted, no significant differences existed between the DMSO and (+)blebbistatin groups. Rockout exposure resulted in significant reductions in perimeter and
cross-sectional area of the ventricle (Figure 17B). Rockout did not significantly alter the
longitudinal or transverse length of the ventricle.
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Figure 16. Reductions in cardiac function following exposure of Xenopus laevis
embryos to blebbistatin and Rockout at stage 26. Cardiac function was analyzed for
treated embryos using parameters at end-diastole (ED). Xenopus laevis embryos were
exposed to either DMSO, (+)-blebbistatin, or (-)-blebbistatin commencing at stage 26
(Panel A). Both DMSO and (+)-blebbistatin, the inactive enantiomer, served as control
groups. No significant differences were observed between the DMSO group and the (+)blebbistatin-treated embryos. There were significant reductions in cross-sectional area of
the ventricular cavity (CSAV) and ventricular wall thickness (VWT) for the embryos
exposed to (-)-blebbistatin compared to both of the control groups. No significant
differences were observed for volume of blood in the ventricular cavity (VV) between
any of the groups. As well, Xenopus laevis embryos were exposed to either DMSO
(control) or Rockout initiating at stage 26 (Panel B). Cardiac function at end-diastole was
examined and a significant reduction in VWT was observed in the Rockout-treated
group. CSAV and VV were not significantly different between the two groups. Analysis
of functional data was performed using a two-way ANOVA paired with a Sidak test. The
end bars represent ±SEM. n = 6 for each group; *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001
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Figure 17. Reductions in ventricular size in Xenopus embryos exposed to
blebbistatin and Rockout at stage 26. Xenopus laevis embryos were exposed to small
molecules that disrupt cardiogenesis to examine morphological alterations. Xenopus
laevis embryos were exposed to DMSO, (+)-blebbistatin, or (-)-blebbistatin starting at
stage 26 (Panel A). DMSO- and (+)-blebbistatin-treated embryos were considered to be
control groups. Significant differences in ventricular parameters were not observed
between the two control groups. In contrast, significant reductions were observed in
transverse length (TL), perimeter (P), and cross-sectional area (CSA) of the ventricle in
the (-)-blebbistatin group compared to both control groups. No significant differences
were identified between any of the groups with respect to longitudinal length (LL) of the
ventricle. Stage 26 Xenopus embryos were also exposed to DMSO (control) or Rockout
(Panel B). No significant differences were observed between the DMSO- and Rockouttreated groups when comparing LL and TL of the ventricle. Significant ventricular
reductions in P and CSA were detected for the Rockout-exposed embryos. Ventricular
morphology was assessed following fixation and in situ hybridization of embryos using
an antisense mRNA probe against cardiac troponin I. Analysis of morphology data used
a two-way ANOVA paired with a Sidak test and the end bars represent ±SEM. n = 58,
36, 56 for the DMSO, (+)-blebbistatin, and (-)-blebbistatin groups, respectively; n = 66
and 69 for the DMSO- and Rockout-treated groups, respectively; *p ≤ 0.05; **p ≤ 0.01;
***p ≤ 0.001; ****p ≤ 0.0001
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3.3.1.2

Treatment of Xenopus laevis embryos at stage 33/34 with
blebbistatin and Rockout

Xenopus laevis embryos were exposed to the respective treatments initiating at stage
33/34. During this developmental period, the linear heart tube has completely closed and
is beginning to undergo rightward looping to determine chamber and valve formation
(Afouda and Hoppler, 2009; Bartlett et al., 2010; Kolker et al., 2000; Lohr and Yost,
2000; Mohun et al., 2000).
For the blebbistatin treatment, embryos were either exposed to DMSO, (+)-blebbistatin,
or (-)-blebbistatin (Movie 8). No significant functional alterations were observed
following exposure to (-)-blebbistatin when compared to both control groups (Figure
18A).
Xenopus embryos were exposed to either DMSO or Rockout (Movie 9). Rockout did not
significantly alter cardiac function with respect to any of the parameters examined
(Figure 18B). This included end-diastolic measurements of cross-sectional area of the
ventricular cavity, volume of blood in the ventricular cavity, and ventricular wall
thickness.
Subsequently, Xenopus embryos were fixed such that the myocardium could be labeled
through a whole-mount in situ hybridization using an antisense mRNA probe against
cardiac troponin I. This permitted morphological analysis following cardiac disruption
through inhibition of ROCK activity.
No significant morphological differences were detected in the ventricle size following
exposure to (-)-blebbistatin commencing at stage 33/34 (Figure 19A).
As well, no significant differences were observed between the control and Rockouttreated groups for longitudinal length, transverse length, and perimeter of the ventricle
(Figure 19B). However, a statistically significant increase was observed in cross-sectional
area for the Rockout-exposed embryos.
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Figure 18. Cardiac function was not significantly altered in Xenopus embryos
exposed to blebbistatin and Rockout at stage 33/34. Cardiac function was compared
for Xenopus embryos following disruption of cardiac development at stage 33/34.
Xenopus laevis embryos were immersed in DMSO, (+)-blebbistatin, or (-)-blebbistatin
(Panel A). Both the DMSO-treated and (+)-blebbistatin-treated embryos served as control
groups since (+)-blebbistatin is an inactive enantiomer. Cardiac function at end-diastole
(ED) was analyzed and significant differences were absent between any of the treatment
groups examined. Parameters examined included cross-sectional area of the ventricular
cavity (CSAV), volume of blood in the ventricular cavity (VV), and ventricular wall
thickness (VWT). Panel B displays the Rockout experiment in which Xenopus laevis
embryos were exposed to the control vehicle (DMSO) or Rockout. No significant
functional differences were observed between the treatment groups. The data analysis
required a two-way ANOVA paired with a Sidak test and the end bars represent ±SEM. n
= 6 for each group
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Figure 19. Exposure of Xenopus embryos to blebbistatin at stage 33/34 did not
significantly alter ventricular morphology, although Rockout exposure resulted in
an increase in ventricular dimension. Cardiogenesis was disrupted using blebbistatin or
Rockout commencing at stage 33/34 to examine morphological changes. Panel A depicts
Xenopus laevis embryos that were exposed to DMSO, (+)-blebbistatin, or (-)-blebbistatin.
There were no significant differences between the three treatment groups examined. The
ventricular parameters used for the examination of cardiac morphology included
longitudinal length (LL), transverse length (TL), perimeter (P), and cross-sectional area
(CSA). Panel B displays Xenopus embryos exposed to either DMSO (control) or
Rockout. No significant ventricular differences were detected between the DMSO- and
Rockout-treated groups when comparing LL, TL, and P. A significant increase in
ventricular CSA was observed for the embryos exposed to Rockout. Ventricular
morphology was assessed following embryo fixation and whole mount in situ
hybridization using an antisense mRNA probe against cardiac troponin I. Morphological
data was compared using a two-way ANOVA paired with a Sidak test. The end bars
represent ±SEM. n = 20, 24, 49 for the DMSO, (+)-blebbistatin, and (-)-blebbistatin
groups, respectively; n = 33 and 37 for the DMSO and Rockout groups, respectively;
****p ≤ 0.0001
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3.3.1.3

Conclusions

The data demonstrates that (-)-blebbistatin does disrupt cardiac function and morphology
when embryos are exposed at stage 26. There was an overall decrease in ventricular
morphology and function in the group treated with the active enantiomer. Conversely, no
significant cardiac alterations were recorded following exposure to (-)-blebbistatin at
stage 33/34.
Rockout also appears to induce changes in cardiac morphology and function that are
reminiscent of the embryos exposed to (-)-blebbistatin. However, Rockout-treated
embryos did not display as severe of a phenotype and cardiac looping defects were
absent.

3.3.2

Retinoic Acid and Retinoic Acid Receptor Antagonist

The rationale for using these small molecules primarily arose from observations that
cardiogenesis is disrupted in Xenopus embryos after exposure to RA and RAA during
neurulation (Collop et al., 2006). Embryos that received exogenous retinoic acid
demonstrated smaller hearts although a heart tube was fully formed. However, embryos
with blocked RA signaling through exogenous treatment with retinoic acid receptor
antagonists demonstrated lack of proper tube formation, although myocardial
differentiation was still observed.
My project involved exposing embryos to RA and RAA commencing at stages 14, 26 and
33/34. Embryos were divided and submerged in DMSO, RA, or RAA, with DMSO
serving as the control group. Xenopus embryos were exposed to the respective treatment
for 24 hours at room temperature before being transferred to 20% Steinberg’s solution.
Embryos were maintained until maturing to stage 46 and onwards prior to cardiac
imaging and fixation.
I performed whole mount in situ hybridization to label the myocardium using an
antisense mRNA probe that selectively labels cardiac troponin I. The cardiac
morphology of embryos in both the control and treated groups are displayed following
treatment (Figure 20A). The HeartMetrics videos enabled the ability to visualize cardiac
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looping defects following disruption of retinoic acid signaling with RA and RAA, except
no looping defects were apparent following exposure to RAA at the latest stage
examined.
Heart rate was measured to examine the effect of disturbing RA signaling on cardiac
rhythmicity (Figure 20B). RA and RAA exposure did not result in statistically significant
effects following exposure at the two later stages. Exposure at stage 14 resulted in a
significantly reduced heart rate for the RA- and RAA-treated groups compared to the
control.
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Figure 20. Xenopus laevis embryos had reductions in heart rate and ventricular
dimensions following exposure to retinoic acid and retinoic acid receptor antagonist.
Xenopus embryos were either exposed to DMSO (control), retinoic acid (RA), or retinoic
acid receptor antagonist (RAA) commencing at stages 14, 26, and 33/34. Whole mount in
situ hybridization was performed on Xenopus embryos using an antisense mRNA probe
against cardiac troponin I to selectively outline the myocardium (Panel A). RA and RAA
exposure resulted in decreased ventricular dimensions compared to the control. As well,
heart rate was compared to examine the effect of disrupting retinoic acid signaling on
cardiac rhythmicity (Panel B). No significant differences were observed for heart rate
following exposure at stages 26 and 33/34. A significant reduction in heart rate was
observed following exposure to both RA and RAA at stage 14. Heart rate was measured
in beats per minute (bpm) and compared using a two-way ANOVA paired with a Sidak
test. The end bars represent ±SEM. n = 6 for treatment at stages 14 and 33/34; n = 8 for
treatment at stage 26; *p ≤ 0.05; ****p ≤ 0.0001
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3.3.2.1

Treatment of Xenopus laevis embryos at stage 14 with RA
and RAA

Treatment at stage 14 required exposure of the embryos either to DMSO, RA (Movie 10),
or RAA (Movie 11). This stage represents an interval in neurulation that is prior to the
migration of the two cardiac anlages that later form a single linear heart primordium,
although specification has occurred by this time (Kolker et al., 2000; Lohr and Yost,
2000; Mohun et al., 2000).
A significant decrease was observed for cross-sectional area of the ventricular cavity and
ventricular wall thickness when comparing the RA- and RAA-exposed embryos to the
control group at end-diastole (Figure 21A). No significant differences in volume of blood
in the ventricular cavity were observed. There were no significant differences observed
between the RA- and RAA-treated groups.
Following analysis of cardiac function, Xenopus embryos were fixed and analyzed by in
situ hybridization. An antisense mRNA probe recognizing cardiac troponin I mRNA was
used to selectively label the myocardium such that cardiac morphology could be
examined (Figure 21B). Ventricular reductions were observed in the RA-treated group
for transverse length, perimeter, and cross-sectional area compared to the DMSOexposed embryos. The RAA-treated group had a significantly decreased perimeter and
cross-sectional area compared to the control group. The transverse length did not differ
between the RAA- and DMSO-treated embryos. Longitudinal length of the ventricle was
not significantly different between any of the groups. The RA- and RAA-treated embryos
were not statistically different, except for the cross-sectional area of the ventricle, which
was significantly reduced in the RA-treated group.
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Figure 21. Exposure of Xenopus laevis embryos to retinoic acid and retinoic acid
receptor antagonist at stage 14 resulted in decreased cardiac function and altered
morphology. In order to examine the effect of disrupted retinoic acid signaling, Xenopus
embryos were exposed either to DMSO, retinoic acid (RA), or retinoic acid receptor
antagonist (RAA) commencing at stage 14. Cardiac function was analyzed using
parameters at end-diastole (ED) (Panel A). A significant reduction was observed for both
the RA- and RAA-treated groups when compared to the control group for cross-sectional
area of the ventricular cavity (CSAV) and ventricular wall thickness (VWT). No
significant functional differences were identified between the RA- and RAA-treated
groups. Volume of blood in the ventricular cavity (VV) was not altered following
treatment with either RA or RAA. Panel B displays the comparison of ventricular
morphology following in situ hybridization using an antisense mRNA probe against
cardiac troponin I. No significant differences were observed for longitudinal length (LL)
when comparing all three groups. Significant reductions were observed for perimeter (P)
and cross-sectional area (CSA) for both the RA- and RAA-treated groups when compared
to the control embryos. A significant reduction was detected for transverse length (TL) of
the ventricle after treatment with RA compared to the control, while no significant
difference was observed for this parameter when comparing RAA- and DMSO-treated
embryos. There were no significant differences observed between the RA- and RAAtreated embryos, except with respect to CSA. A two-way ANOVA paired with a Sidak
test was used to analyze the cardiac data. As well, the end bars represent ±SEM. n = 6 for
each group for the functional analysis; n = 85, 61, and 67 for the DMSO-, RA-, and
RAA-exposed embryos, respectively, for the morphological comparison; *p ≤ 0.05; **p
≤ 0.01; ****p ≤ 0.0001
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3.3.2.2

Treatment of Xenopus laevis embryos at stage 26 with RA
and RAA

Treatment at stage 26 was used to disrupt cardiogenesis immediately prior to cardiac
differentiation and during closure of the linear heart tube (Kolker et al., 2000; Lohr and
Yost, 2000; Mohun et al., 2000). For this experiment, Xenopus laevis embryos were
exposed to DMSO (control), RA (Movie 12), or RAA (Movie 13) to analyze the effect
that disruption of retinoic acid signaling would have on cardiogenesis.
There were no significant functional differences between the RAA- and DMSO-exposed
groups for any of the diastolic parameters examined (Figure 22A). No significant
functional differences were observed between any of the groups when comparing volume
of blood in the ventricular cavity. Conversely, a significant reduction was detected in the
RA-treated group when compared to the control embryos for cross-sectional area of the
ventricular cavity. There was no statistically significant difference detected between the
RA- and RAA-treated groups for cross-sectional area of the ventricular cavity. A
significant reduction was observed for diastolic ventricular wall thickness for embryos
exposed to RA compared to both of the other groups.
Following analysis of cardiac function, Xenopus embryos were fixed such that in situ
hybridization could be performed to selectively stain the myocardium for morphological
comparison (Figure 22B). No significant differences were observed when comparing all
three groups in terms of longitudinal and transverse length of the ventricle. Significant
differences were observed when analyzing cross-sectional area of the ventricle with
reductions observed in the RA- and RAA-treated groups compared to the control. A
significant reduction in perimeter of the ventricle was observed in the RAA-treated group
compared to the control embryos. There was no significant difference observed for
perimeter following comparison of the DMSO- and RA-exposed embryos. No significant
differences were observed between the RA- and RAA-treated groups.
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Figure 22. Retinoic acid and retinoic acid receptor antagonist exposure initiating at
stage 26 resulted in reductions in ventricular morphology and function. To observe
the effects of disturbing retinoic acid signaling, Xenopus embryos were exposed to either
DMSO, retinoic acid (RA) or retinoic acid receptor antagonist (RAA) initiating at stage
26. Functional examination at end-diastole (ED) detected no significant differences
between the RAA and control group for all three diastolic parameters examined (Panel
A). Significant reductions in cross-sectional area of the ventricular cavity (CSAV) and
ventricular wall thickness (VWT) were observed for the RA-treated group when
compared to the DMSO-exposed embryos. The volume of blood in the ventricular cavity
(VV) was not significantly altered between any of the groups. A significant difference
between the RA and RAA groups was only observed for VWT. Panel B shows the
comparison of ventricular morphology following embryo fixation and whole mount in
situ hybridization. No significant differences were observed for longitudinal length (LL)
or transverse length (TL) when comparing every group. Significant reductions in
perimeter (P) and cross-sectional area (CSA) of the ventricle were detected in the RAAtreated group compared to the DMSO-treated embryos. Although no significant
difference was observed for P, there was a significant reduction in CSA for RA-treated
embryos compared to the control group. There were no statistically significant
differences detected between the RA- and RAA-exposed embryos. Functional and
morphological data was compared using a two-way ANOVA paired with a Sidak test.
The end bars represent ±SEM. n = 8 for each group for the functional comparison; n =
28, 19, and 17 for the DMSO, RA, and RAA groups, respectively, for the morphological
comparison; *p ≤ 0.05; ***p ≤ 0.001; ****p ≤ 0.0001
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3.3.2.3

Treatment of Xenopus laevis embryos at stage 33/34 with
RA and RAA

Stage 33/34 corresponds to a period when the linear heart tube has completely closed and
is beginning to undergo rightward looping (Afouda and Hoppler, 2009; Bartlett et al.,
2010; Kolker et al., 2000; Lohr and Yost, 2000; Mohun et al., 2000). This looping
process is essential for proper chamber and valve formation. Initiating at stage 33/34,
Xenopus embryos were exposed either to DMSO (control), exogenous RA (Movie 14), or
RAA (Movie 15).
Based on the functional comparison, significant decreases in cross-sectional area of the
ventricular cavity and ventricular wall thickness were identified in the RA-treated
embryos compared to the other two groups (Figure 23A). There were no significant
functional differences observed between the RAA- and DMSO-exposed groups. Volume
of blood in the ventricular cavity was not altered for any of the groups.
After examining cardiac function, Xenopus embryos were fixed to undergo in situ
hybridization using a myocardium-specific antisense mRNA probe in order to compare
ventricular morphology (Figure 23B). There were no significant differences observed.

3.3.2.4

Conclusions

This novel imaging system was able to detect significant alterations in cardiac function
and morphology following disruption of retinoic acid signaling at various developmental
time points. Overall, reductions in ventricular dimension were observed following
disruption of retinoic acid signaling. Furthermore, cardiac looping defects were generally
observed after exposure to RA or RAA.
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Figure 23. Disruption of retinoic acid signaling resulted in significant reductions in
cardiac function, but did not result in statistically significant changes in ventricular
morphology. The functional and morphological effects resulting from disturbances in
retinoic acid signaling were examined in Xenopus embryos using exogenous retinoic acid
(RA) and retinoic acid receptor antagonist (RAA). Embryos were exposed to DMSO,
RA, or RAA commencing at stage 33/34 and analyzed at end-diastole (ED) for functional
alterations (Panel A). Significant reductions were observed for cross-sectional area of the
ventricular cavity (CSAV) and ventricular wall thickness (VWT) in the RA-treated group
compared to the two other groups. RAA- and DMSO-exposed embryos were not
significantly different in cardiac function. No significant differences were observed
following examination of volume of blood in the ventricular cavity (VV). Panel B shows
the comparison of ventricular morphology. There were no statistically significant
alterations observed. Ventricular parameters examined included longitudinal length (LL),
transverse length (TL), perimeter (P), and cross-sectional area (CSA). This was examined
following in situ hybridization using an antisense mRNA probe against cardiac troponin
I. A two-way ANOVA paired with a Sidak test was used to compare the parameters, as
well as the end bars represent ±SEM. n = 6 for each group for the functional comparison;
n = 19, 31, and 20 for the DMSO, RA, and RAA groups, respectively, for the
morphological comparison; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
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3.3.3

Ethanol

My next experiments involved deviating from small molecules previously used in our
lab. A plethora of research has been dedicated to confirming ethanol’s role as a teratogen
leading to the development of fetal alcohol syndrome (FAS) (Jones and Smith, 1973). It
is estimated that approximately 54% of children that have been associated with symptoms
of FAS have been shown to display corresponding cardiac defects (Abel, 1990).
A study conducted by Yelin et al. demonstrated that exposure to various concentrations
of ethanol caused cardiac defects in Xenopus embryos (Yelin et al., 2007b). A majority of
embryos exposed to 1.5% ethanol during the mid-blastula transition showed changes in
cardiac morphology including less mature trabeculae. Therefore, I sought to verify those
findings using our high-speed video camera and HeartMetrics software. Since trabeculae
are contiguous with the ventricular wall in my experiments, then I expect a reduction in
ventricular wall thickness following ethanol exposure to correspond with the less mature
trabeculae observed by the other research group.
I exposed Xenopus laevis embryos to either a control solution (20% Steinberg’s solution)
or 1.5% ethanol dissolved in 20% Steinberg’s solution. Xenopus embryos were
maintained in the respective treatments until stage 46 and onwards, at which point cardiac
imaging and fixation were performed.
Representative embryos from both the control and ethanol-treated groups are shown
below after treatment at stages 8.5, 26, and 33/34 (Figure 24A). The figure depicts the in
situ hybridization images that outline the myocardium. The HeartMetrics program
allowed for the visualization and identification of relatively normal cardiac looping
following ethanol exposure, except for looping abnormalities when exposed at stage 8.5.
Heart rate was measured and analyzed following embryo exposure to ethanol (Figure
24B). Ethanol exposure did not cause statistically significant changes in heart rate,
regardless of the stage of treatment.
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Figure 24. Xenopus laevis embryos exposed to ethanol displayed altered cardiac
morphology and no significant differences in heart rate. Ethanol treatment of Xenopus
embryos initiated at stages 8.5, 26, and 33/34 and embryos were exposed either to 20%
Steinberg’s solution (control) or 1.5% ethanol. Subsequently, whole mount in situ
hybridization was performed using an antisense mRNA probe against cardiac troponin I
to outline the myocardium (Panel A). Reductions in ventricular dimensions were
observed following exposure to ethanol. Relatively normal cardiac looping was also
noted following imaging using HeartMetrics, except following treatment at stage 8.5.
Additionally, the effect of ethanol on heart rate was compared (Panel B). Ethanol was not
determined to cause statistically significant alterations in heart rate at any of the stages
targeted. Heart rate was measured in beats per minute (bpm) and analysis of data
involved a two-way ANOVA paired with a Sidak test. The end bars represent ±SEM. n =
16 and 17 for the control and ethanol groups, respectively, for exposure at stage 8.5; n =
15 and 20 for the control and ethanol groups, respectively, for exposure at stage 26; n =
15 and 16 for the control and ethanol groups, respectively, for exposure at stage 33/34
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3.3.3.1

Treatment of Xenopus laevis embryos at stage 8.5 with
ethanol

Embryos were treated at stage 8.5 during the mid-blastula transition and immersed in
either Steinberg’s solution, which served as the control group, or 1.5% ethanol (Movie
16) (Nieuwkoop and Faber, 1994). Stage 8.5 represents a time point in development that
precedes the induction of cardiac progenitors (Afouda and Hoppler, 2009; Lohr and Yost,
2000).
Functional comparison revealed that ventricular wall thickness at end-diastole was
significantly reduced in embryos exposed to ethanol compared to the control (Figure
25A). Cross-sectional area of the ventricular cavity and volume of blood in the
ventricular cavity were not significantly affected by ethanol exposure.
Subsequently, embryos were fixed and underwent an in situ hybridization to outline the
myocardium using an antisense mRNA probe against cardiac troponin I mRNA. This
permitted the measurement of several ventricular dimensions to elucidate cardiac
morphology changes following exposure to ethanol (Figure 25B). There were significant
reductions in longitudinal length, transverse length, and perimeter of the ventricle for
ethanol-treated embryos. However, ethanol had no effect on the cross-sectional area of
the ventricle.
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Figure 25. Ethanol exposure at stage 8.5 caused reductions in ventricular
morphology and cardiac function. Xenopus laevis embryos were either exposed to 20%
Steinberg’s solution (control) or 1.5% ethanol commencing at stage 8.5. Cardiac function
was analyzed at end-diastole (ED) and a significant reduction in ventricular wall
thickness (VWT) was observed in the ethanol-exposed group (Panel A). There were no
significant alterations following ethanol exposure for cross-sectional area of the
ventricular cavity (CSAV) and volume of blood in the ventricular cavity (VV). In situ
hybridization images were used to compare cardiac morphology (Panel B). There were
significant reductions in the ethanol-treated group for several ventricular parameters
including longitudinal length (LL), transverse length (TL), and perimeter (P). Ethanol
exposure did not result in a statistically significant difference for cross-sectional area
(CSA) of the ventricle. A two-way ANOVA paired with a Sidak test was used to assess
the cardiac data. The end bars represent ±SEM. n = 16 and 17 for the control and ethanoltreated groups, respectively, for the functional comparison; n = 83 and 67 for the control
and ethanol groups, respectively, for the morphological comparison; **p ≤ 0.01; ****p ≤
0.0001
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3.3.3.2

Treatment of Xenopus laevis embryos at stage 26 with
ethanol

Xenopus embryos were immersed in ethanol initiating at stage 26 in order to evaluate
cardiac disruption at a developmental period directly preceding cardiac differentiation
and overlapping with closure of the linear heart tube (Kolker et al., 2000; Lohr and Yost,
2000; Mohun et al., 2000). The embryos were divided into two treatment groups, either
20% Steinberg’s solution (control) or 1.5% ethanol (Movie 17).
Comparison of cardiac function revealed no statistically significant alterations when
comparing cross-sectional area of the ventricular cavity and volume of blood in the
ventricular cavity at end-diastole (Figure 26A). A statistically significant reduction in
ventricular wall thickness at end-diastole was observed in the ethanol-treated group
compared to the control.
Afterwards, the Xenopus embryos were fixed in preparation for in situ hybridization,
which permitted analysis of static ventricular parameters to examine cardiac morphology
changes (Figure 26B). Ethanol treatment was associated with significant decreases in
transverse length and perimeter. Longitudinal length and cross-sectional area were not
significantly different between the two groups.
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Figure 26. Reductions in cardiac function and morphology following exposure to
ethanol commencing at stage 26. Initiating at stage 26, Xenopus embryos were either
exposed to 20% Steinberg’s solution (control) or 1.5% ethanol. Panel A displays the
comparison of cardiac function for end-diastolic (ED) parameters. A significant reduction
in ventricular wall thickness (VWT) was detected following ethanol exposure. There
were no significant differences regarding cross-sectional area of the ventricular cavity
(CSAV) and volume of blood in the ventricular cavity (VV). Subsequently, embryos
underwent an in situ hybridization to examine ventricular morphology (Panel B).
Statistically significant reductions were observed for transverse length (TL) and
perimeter (P) of the ventricle in the ethanol-exposed group. There were no significant
differences for longitudinal length (LL) and cross-sectional area (CSA). A two-way
ANOVA paired with a Sidak test was used to analyze the cardiac parameters. The end
bars represent ±SEM. n = 15 and 20 for the control and ethanol groups, respectively, for
the functional analysis; n = 62 and 57 for the control and ethanol-treated groups,
respectively, for the morphological analysis; **p ≤ 0.01; ****p ≤ 0.0001

99

3.3.3.3

Treatment of Xenopus laevis embryos at stage 33/34 with
ethanol

To elucidate on functional changes following ethanol treatment, Xenopus embryos were
either exposed to 20% Steinberg’s solution (control) or 1.5% ethanol (Movie 18) starting
at stage 33/34. This developmental period corresponds to the initiation of cardiac looping
following complete closure of the cardiac tube (Afouda and Hoppler, 2009; Bartlett et al.,
2010; Kolker et al., 2000; Lohr and Yost, 2000; Mohun et al., 2000).
Analysis of cardiac function showed that ethanol exposure resulted in a significant
reduction in ventricular wall thickness at end-diastole compared to the control embryos
(Figure 27A). Cross-sectional area of the ventricular cavity and volume of blood in the
ventricular cavity were not significantly altered.
Next, embryos underwent an in situ hybridization to examine ventricular morphology
(Figure 27B). Significant reductions in transverse length and perimeter resulted from
ethanol exposure. There were no significant differences between the two groups
regarding longitudinal length and cross-sectional area.

3.3.3.4

Conclusions

Therefore, our system was able to corroborate the findings published by Yelin et al. that
described less mature trabeculae following exposure to 1.5% ethanol at stage 8.5 (Yelin
et al., 2007b). This corresponds to the reduction in ventricular wall thickness observed in
my experiments. The functional and morphological reductions resulting from ethanol
exposure were observed following treatment at each developmental interval targeted.
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Figure 27. Xenopus embryos exposed to ethanol initiating at stage 33/34 displayed
reductions in ventricular morphology and function. Beginning at stage 33/34,
Xenopus laevis embryos were either exposed to 20% Steinberg’s solution (control) or
1.5% ethanol. Cardiac function was compared at end-diastole (ED) and displayed in
panel A. Ventricular wall thickness (VWT) was significantly reduced following ethanol
exposure. Cross-sectional area of the ventricular cavity (CSAV) and volume of blood in
the ventricular cavity (VV) were not significantly altered. Subsequently, in situ
hybridizations were performed to permit the collection and comparison of ventricular
dimensions (Panel B). The ethanol-treated group displayed significant reductions in
transverse length (TL) and perimeter (P) compared to the control group. Longitudinal
length (LL) and cross-sectional area (CSA) were not significantly changed. Functional
and morphological data was analyzed using a two-way ANOVA paired with a Sidak test.
The end bars represent ±SEM. n = 15 and 16 for the control and ethanol groups,
respectively, for the functional analysis; n = 63 and 54 for the control and ethanol groups,
respectively, for the morphological analysis; *p ≤ 0.05; ****p ≤ 0.0001
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3.4 Origin of Cardiac Response
Diverging from the topic of CHDs, we noted that our observations using the modulators
of heart rate would suggest that, at the times we tested, the heart was responding to
neuromodulation. Although many aspects of development are well characterized in
Xenopus, knowledge concerning when cardiac innervation is established is not well
documented. The origin of cardiac response is marked by alterations in cardiac function
following environmental changes, such as the response to chemical stimuli that I
documented. Innervation may imply the existence of a functional nervous system that can
control the response of autonomic tissues, such as cardiac responses (Armour, 1999).
Therefore, I exposed embryos to a classical modulator at earlier time points to gain
insight into the developmental stage when innervation occurs. If the embryo were able to
demonstrate the appropriate cardiac response to the drug, then the embryo would be
considered innervated by that stage. Nkx2.5-GFP transgenic frogs were utilized for
examination of stages 37/38 and 39 in order to potentially improve imaging at the earlier
time points. The Nkx2.5-GFP transgenic embryos should express GFP within the
myocardium before the heart starts beating (Mohun et al., 2000). Wild type embryos do
not image well prior to stage 40 due to optical considerations.
Xenopus laevis embryos were exposed to isoproterenol and assessed for an increase in
heart rate. An increase in heart rate upon exposure to the drug would indicate innervation
had already been established (Cirić and Susić, 1980). There was a consistent, but
variable, increase in heart rate after isoproterenol exposure (Figure 28). This response
was observed for each stage examined, including stages 37/38 to 45. A value on the yaxis that was greater than zero would indicate an increase in heart rate from baseline.
In conclusion, my data suggests that innervation in Xenopus laevis embryos occurs by at
least stage 37/38 during embryonic development since the proper cardiac response was
observed. Unfortunately, our imaging system was not capable of visualizing and
measuring heart rate at earlier stages due to the opacity of the embryos. Nevertheless,
these experiments did elucidate on a narrower interval in which this developmental
process occurs.

103

Figure 28. Xenopus laevis embryos are capable of displaying expected cardiac
responses to pharmacological agents by at least stage 37/38. This experiment involved
measuring the baseline heart rate of embryos ranging from stages 37/38 to 45.
Subsequently, embryos were exposed to isoproterenol, which is well documented to
increase heart rate. Overall, an increase in heart rate was observed indicated by a positive
change in heart rate. Hence, this data suggests that embryos are capable of responding to
the presence of pharmacological agents by stage 37/38. Furthermore, since autonomic
responses, such as a cardiac response, to a classical modulator of heart rate possibly relies
on the presence of a functional nervous system, hence it is expected that the Xenopus
laevis embryo may be innervated by at least stage 37/38. The end bars represent ±SEM. n
= 3-4 for each group
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Chapter 4

4

Discussion

My primary aim for this project was to develop methods of evaluating heart function in
Xenopus laevis embryos. To do this, I tailored a video imaging and analysis system that
was previously used in chick for use in Xenopus and, if successful, this imaging system
could serve as a valuable alternative to current imaging modalities at elucidating
mechanisms underlying congenital heart defects.
I conclude that this system is capable of accurately measuring cardiac function in
Xenopus laevis embryos. To support my conclusion, I will discuss the normative sample
data and the classical modulators of heart rate.

4.1 Measurements of Normal Cardiac Function
General increases in cardiac function were observed within the control embryos. An
increase in heart rate was observed upon maturation of the embryo from stages 45
through 48. Similarly, increases in ventricular wall thickness at both end-diastole and
end-systole were also detected as embryos developed from stages 45 to 48. This increase
in wall thickness was accompanied by an increase in stroke volume and cardiac output.
Furthermore, I noted that flow velocity between embryos displayed large variability. A
study conducted in human fetuses using cardiac Doppler tracing estimated the standard
error of maximum flow velocity to be 11 to 26 mm/s (Reed et al., 1986). Therefore, the
high level of variability for flow velocity observed in human fetuses is consistent with the
broad variability seen in my experiments using Xenopus embryos.

4.1.1

Comparison of our Data to the Previous Measures of
Cardiac Function

A simple method for evaluating our video imaging system’s measurements is through a
comparison to the previous studies using different modalities.
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Cardiac function in anesthetized stage 47 Xenopus laevis embryos has been analyzed
using optical coherence tomography (OCT) (Boppart et al., 1997). This method utilizes
the innate ability of biological tissues to reflect light waves. Essentially, light waves are
emitted from the equipment towards the biological tissue of interest and subsequently this
light is reflected within a range of delay times depending on the tissue composition. This
delay time is referred to as the echo delay, which is interpreted to compile cross-sectional
images using interferometry. In this study, the heart rate was determined to be
approximately 128 beats per minute, which is comparable to the average 139 bpm
determined through my experiments. The end-diastolic dimension (EDD) and endsystolic dimension (ESD) were observed to be 666 and 398 microns, respectively.
Conversely, I determined the EDD and ESD to be an average of 338 and 246 microns,
respectively (see Appendices). Although the raw values are different, my data
corroborated with the EDD:ESD ratio of approximately 3:2. Importantly, the end
dimension computations by Boppart et al. included both the ventricular cavity as well as
the ventricular wall, although a majority of end dimension calculations generally only
include the ventricular cavity.
Another publication examined cardiac function using Doppler optical coherence
tomography (DOCT), which is similar to OCT except with Doppler extensions (Yang et
al., 2003). This technique is more closely analogous to Doppler ultrasound. The DOCT
system was capable of obtaining a maximum frame rate of 32 frames per seconds. Using
this system, flow velocity in the left and right aortic branches was measured following
anesthetization of stage 47 Xenopus laevis embryos. The computations indicated at a
maximum erythrocyte velocity of 9mm/s. My data suggests that the flow velocity of stage
48 embryos that were not anesthetized was an average of 4mm/s and ranged from 28.4mm/s. Therefore, this is comparable to the values that I have observed using our
imaging system, which suggests that our system is accurate, although the small
differences would require a direct comparison of methodology and staging of embryos.
The ventricular dimensions of fixed, stage 49 embryos have been imaged (Yelin et al.,
2007b). In that study, the ventricle was imaged using full-field optical coherence
tomography (FFOCT), which uses low-coherence interferometry. The ventricular wall
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thickness (including the trabeculae) during maximum filling of the ventricle could be
approximated to be slightly greater than 100µm. Although I did not examine Xenopus
embryos at stage 49, at the slightly earlier stage 48, I measured a diastolic ventricular
wall thickness of 74µm. Since 7.5 days at room temperature is required to reach stage 48,
but an additional 4.5 days is necessary to mature to stage 49, it could be hypothesized that
ventricular wall thickness increases considerably during this period. To test this
hypothesis, we need to modify our system to optimize imaging at a later stage of
development.
My findings are consistent with evidence from a group that studied a very closely related,
but smaller species, Xenopus tropicalis, that can also be staged using the Nieuwkoop and
Faber staging table (Deniz et al., 2012). Analysis of the tropicalis embryos determined
that the ejection fraction was approximately 100% when assayed using hemoglobin
contrast subtraction angiography, which exploits the use of hemoglobin as an endogenous
contrast agent. The ventricle is devoid of blood at end-systole represented by the absence
of black regions, whereas the ventricle at end-diastole contained a substantial amount of
hemoglobin. We confirmed the complete emptying of the ventricle following a cardiac
contraction in Xenopus laevis using our system (For an example, see Movie 1), which
supports the tropicalis data (Deniz et al., 2012).

4.1.2

Classical Modulators of Heart Rate

Further validation that our video system can clearly measure changes in function used
exposure to known modulators of heart rate that have well-established effects. As
expected, a dose-dependent increase in heart rate was observed following exposure to
atropine, epinephrine, and isoproterenol. Conversely, a concentration-dependent decrease
in heart rate was observed following exposure to metoprolol. The imaging system was
able to detect alterations in heart rate and thus could potentially be used as an assay for
screening of small molecules for cardiac activity in Xenopus embryos.
Next, I will discuss the results following disruption of cardiogenesis to further examine
how this novel imaging system could be advantageous for the investigation of CHDs.
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4.2 Novel Assessments of Changes in Function
4.2.1

Rationale for Blebbistatin and Rockout

The role of Rho and ROCK in cardiac development has been defined in several species,
including chick and zebrafish (Dickover et al., 2014; Sakata et al., 2007). In zebrafish,
inhibition of RhoU signaling caused morphological disruptions, such as defects in the
formation of the atrioventricular canal and improper cardiac looping (Dickover et al.,
2014). RhoU was identified to be a regulator of cell junctions between myocardial cells
through a pathway involving Arhgef7b/Pak kinase. Studies in the chick revealed that
inhibition of ROCK activity through the small molecule Y27632 resulted in disruption in
striated myofibril formation in the heart (Sakata et al., 2007). This inhibition also caused
improper formation of the costamere, which is a site for adhesion between the Z-band
and sarcolemma. These results suggest a role for ROCK in cell-cell adhesion required for
myofibrillogenesis. Therefore, since both blebbistatin and Rockout inhibit ROCK
signaling, then both of these small molecules would be predicted to cause morphological
defects and possibly functional changes as well.
Blebbistatin was selected for generating defects in cardiogenesis because this small
molecule is known to inhibit crucial processes required for the signaling pathway of
Shroom3 (Figure 29) (Plageman et al., 2011a). Shroom3 was first identified for the ability
to cause embryonic lethality resulting from exencephaly and spina bifida (Hildebrand and
Soriano, 1999). The role of Shroom3 is currently being studied by the Drysdale lab and
has already been linked to CHDs in mice (Halabi, 2013). Moreover, Shroom3 plays a
crucial role in the regulation of cell shape of epithelial cells located in the lens, gut, and
neural tube (Chung et al., 2010; Hagens et al., 2006; Haigo et al., 2003; Hildebrand and
Soriano, 1999; Lee et al., 2009; Plageman et al., 2010, Plageman et al. 2011a; Suzuki et
al., 2012).
Localization of Shroom3 at the adherens junctions allows interaction with β-catenin and
F-actin (Suzuki et al., 2012). The ASD2 domain of Shroom3 is responsible for directly
interacting with Rho-associated kinases (ROCKI and ROCKII) (Nishimura and Takeichi,
2008). Shroom3’s activity requires that the Rho-associated kinases phosphorylate the
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myosin light chain (MLC) of non-muscle myosin II to activate NM-II. Overall, this
signaling cascade ultimately culminates in apical constriction (Nishimura and Takeichi,
2008; Quintin et al., 2008).
Hence, exposure to either a Rho-associated kinase inhibitor, such as Rockout, or a nonmuscle myosin II inhibitor, such as blebbistatin, can result in the inability of proper cell
shape changes in epithelial cells (Hildebrand, 2005; Kinoshita et al., 2008; Plageman et
al., 2011b; Wei et al., 2001).
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()))BlebbistaEn'

Shroom3'

Rho)associated'kinases'
(ROCKI/II)'

Non)muscle'myosin'II'
(pMLC)'

AcEn'

(apical'constricEon)'

RockOUT'

Figure 29. A simplified version of the Shroom3 pathway. This simplified version of
the Shroom3 pathway indicates at some key regulatory proteins required for apical
constriction of epithelial cells. Shroom3 physically interacts with Rho-associated kinases
(ROCKI and ROCKII) to directly mediate its activity. Subsequently, activation of Rhoassociated kinases results in the phosphorylation of the myosin light chain of non-muscle
myosin II. Next, this results in the eventual apical constriction of epithelial cells through
the role of actin. This diagram illustrates the mechanisms in which two small molecule
inhibitors, Rockout and blebbistatin, act on key regulatory proteins to inhibit Shroom3’s
activity and prevent appropriate apical constriction.
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4.2.2

Blebbistatin

Significant effects of (-)-blebbistatin were only observed upon exposure at stage 26.
There were functional and morphological reductions observed following disruption of
ROCK signaling. Conversely, a significant increase in heart rate was observed following
exposure to (-)-blebbistatin at stage 26. The absence of significant cardiac alterations
following exposure at stage 33/34 may result from the fact that the developmental
interval targeted does not disturb cardiac differentiation or the fusion to form a single
linear heart tube (Kolker et al., 2000; Lohr and Yost, 2000; Mohun et al., 2000). This
stage was targeted to investigate whether inhibition of ROCK signaling, which is
necessary for apical constriction, would cause defects in cardiac looping (Colas and
Schoenwolf, 2001; Plageman et al., 2011a; Smith and Schoenwolf, 1997). ROCK
activation has been shown to be a key regulator in the phosphorylation and subsequent
activation of myosin light chain. Therefore, blebbistatin would act to inhibit ROCKmediated apical constriction (Allingham et al., 2005; Amano et al., 1996; Dou et al.,
2007; Swift et al., 2012). As expected, embryos treated with (-)-blebbistatin at both
stages demonstrated cardiac looping defects.
Previous work in the lab demonstrated that morpholino knockdown of shroom3 resulted
in Xenopus laevis embryos that displayed delayed formation of a linear cardiac tube with
smaller ventricles and looping defects (Grover, 2009; Halabi, 2013). I observed similar
defects following (-)-blebbistatin exposure. The decrease in ventricular size that I
observed (refer to Figures 16A and 17A) may be explained by decreased cell thickening
in the myocardium resulting from inhibition of ROCK activity. Importantly, using the
video imaging, we were able to more clearly measure VWT in vivo (refer to Figures 16A
and 18A). Although we would predict a reduction in stroke volume and cardiac output,
however, we could not show that the changes are functionally relevant as I was not able
to measure the endocardial border at end-systole. This will be addressed further in the
limitations section.
The gene Heart and Soul (Has) encodes for atypical protein kinase C lambda (aPKC
lambda), which plays a role in the highly conserved Par-aPKC complex (HorneBadovinac et al., 2001; Peterson et al., 2001). This complex is localized to the adherens
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junctions and serves a role in epithelial polarity (Izumi et al., 1998; Kuchinke et al., 1998;
Müller and Wieschaus, 1996; Ohno, 2001; Petronczki and Knoblich, 2001; Suzuki et al.,
2001; Wodarz et al., 2000). Loss of aPKC lambda in zebrafish was associated with
defects in the retina, neural tube, and gut, including abnormalities in gut looping (HorneBadovinac et al., 2001). Another publication also examining the has mutation in
zebrafish demonstrated that disruption of aPKC lambda resulted in cardiac chamber
misalignment (Peterson et al., 2001). The mutation in has was originally identified to
cause disruptions in cell-cell interactions and was later determined to also result in a
phenotype where the ventricle formed within the atrial zone of the heart tube due to the
disturbances in cellular polarity, which is essential for cardiac tube positioning.
Furthermore, a study screening numerous genes identified mutations in heart and soul to
be associated with a small heart and indistinctive chamber formation in zebrafish
(Stainier et al., 1996). These cardiac defects are similar to the phenotype that I observed
in Xenopus following blebbistatin treatment. RhoA has been shown to be required for
Shroom3-dependent apical constriction and the function and localization of has and
shroom3 are similar (Plageman et al., 2011a). Therefore, the looping and diminished
ventricular size abnormalities that are observed in the gut and heart of zebrafish may
explain the defects observed following disruption of ROCK signaling using blebbistatin
in my Xenopus experiments.

4.2.3

Rockout

Rockout inhibits ROCK signaling, as is the case with blebbistatin (Morckel et al., 2012;
Yarrow et al., 2005). As expected, the Rockout exposure resulted in similar changes as
observed for the blebbistatin treatment. Specifically, there were reductions in both
functional and morphological cardiac measurements upon exposure at stage 26.
Treatment at stage 33/34 did not cause a statistically significant alteration in cardiac
function and morphology, except for a significant increase detected in ventricular crosssectional area. However, the parameter was not associated with any functional changes
and this may be due to the stage specific consequences of ROCK inhibition.
In contrast to exposure to blebbistatin, there were no looping malformations identified
following Rockout treatment. This absence may be the result of Rockout simply not
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being fully effective. This could be confirmed through western blot analysis to observe
levels of phosphorylated myosin light chain, which should be reduced following exposure
to Rockout. The Rockout treatment could be substituted with another small molecule that
inhibits ROCK, such as Y-27632, HA1077, and H-89 (Yarrow et al., 2005).

4.2.4

Retinoic Acid and Retinoic Acid Receptor Antagonist

The cardiac phenotype resulting from absence of retinoic acid signaling can be explained
by research that has demonstrated that retinoic acid is partially responsible for
establishing the posterior boundary of the second heart field (Ryckebusch et al., 2008).
Raldh2-/- murine embryos with a deficiency in the production of retinoic acid
demonstrated failure to undergo proper cardiac looping (Ryckebusch et al., 2008; Sirbu et
al., 2008). This was proposed to be a consequence of decreased Hoxa1 expression. In
contrast, another publication utilizing Raldh2-/- mice demonstrated abnormal positioning
of cardiac structures resulting from an expanded Isl-positive population due to increased
Fgf8 signaling (Sirbu et al., 2008). An additional study identified the essential role for
retinoic acid signaling in the differentiation and renewal of the progenitor population
during addition of cells from the secondary heart field to the outflow tract (Li et al.,
2010). Mice with aberrant retinoic acid receptors demonstrated misalignment of the
outflow tract. This publication identified a retinoic acid deficiency phenotype including
improper looping and absence of adequate trabeculation (Niederreither et al., 2001).
Therefore, these findings corroborate with the looping defects and diminished ventricular
size that were demonstrated following RAA-exposure in my experiments.
Next, I will attempt to explain factors contributing to the cardiac defects observed
following exposure to physiologically excessive levels of retinoic acid. In a study that
used zebrafish as a developmental model, exogenous RA exposure resulted in a dosedependent reduction in dimension and subsequent disappearance of cardiac tissue
(Stainier and Fishman, 1992). From this publication, the assumption would be that higher
than physiological levels of retinoic acid result in small ventricles, which was observed
following RA-treatment in my project. The addition of excess retinoic acid has been
associated with a plethora of cardiac defects, which also corroborates with some of my
observations (Collop et al., 2006).

113

Therefore, my experiments demonstrated that disruption of retinoic acid signaling
resulted in predictable reductions in ventricular morphology in Xenopus laevis embryos
and these were correlated with expected reductions in cardiac function. As well, I
observed reductions in heart rate following both RA and RAA exposure during
neurulation, which is corroborated by previous work in the lab (Collop et al., 2006).
I observed that the RA- and RAA-exposed groups had similar phenotypes. However,
since these treatments represent opposites, then opposing phenotypes may be expected.
The extent of my project hinders my capability to fully explain the mechanism
underlying my findings. A possible explanation may be that the retinoic acid was not
fully effective since cardiac structures should be absent at high doses when treated at
earlier stages, which was not observed in my data (Collop et al., 2006). Alternatives for
inhibiting retinoic acid signaling could be used, such as raldh2-/- embryos, morpholinos
targeting raldh2 mRNA, or an anti-retinoic acid monoclonal antibody (Twal et al., 1995).
These reductions in ventricular dimension and wall thickness may be indicative of
decreased stroke volume and cardiac output, which may ultimately result in pathological
consequences.

4.2.5

Ethanol

Ethanol exposure caused statistically significant reductions in both functional and
morphological parameters following treatment at each developmental interval that was
targeted. The decrease in ventricular wall thickness that was noted in my experiments is
similar to findings using static imaging in Xenopus (Yelin et al., 2007b). Furthermore, a
study demonstrated maximal sensitivity to ethanol during late blastula and early
gastrulation (Yelin et al., 2005). The reduction in ventricular wall thickness observed in
my experiments was most prominent when exposure overlapped with the mid-blastula
transition and this parameter may signify reductions in stroke volume and cardiac output.
Several hypotheses have emerged to explain the symptoms associated with ethanol
exposure during embryonic development. For instance, damage resulting from increased
free-radical generation could be the mechanism underlying the teratogenic effects (Kotch
et al., 1995). Following exposure to ethanol in utero, mice demonstrated increased levels
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of superoxide anions, lipid peroxidation, and cell death and an increased occurrence of
mice with disrupted morphogenesis such as failure of neural tube closure. Rescue
experiments using superoxide dismutase (SOD), which acts as an antioxidant, aided in
decreasing the teratogenic effects observed. Another proposed mechanism for ethanol
teratogenesis includes increased apoptosis, demonstrated through changes in caspase-3
activation, resulting in neurodegeneration in mice (Olney et al., 2002a; Olney et al.,
2002b). Similarly, experiments performed in the chick observed increased incidence of
apoptosis in neural crest cells upon exposure to ethanol (Cartwright and Smith, 1995a).
Alteration of gene expression of specific proteins such as insulin-like growth factors
(IGF) (Singh et al., 1996b) or GLUT1 (Singh et al., 1996a) has also been noted. Another
research group noted reduced epidermal growth factor (EGF)-dependent cell replication
following hepatic exposure to ethanol in fetal rats (Henderson et al., 1989).
One explanation proposed to elucidate the mechanisms underlying the cardiac defects
was the competition of ethanol for metabolism, thereby antagonizing the synthesis of
retinoic acid (Deltour et al., 1996; Duester, 1991; Pullarkat, 1991; Van Thiel et al., 1974;
Yelin et al., 2005; Yelin et al., 2007a). Vitamin A, otherwise referred to as retinol, must
be oxidized by endogenous enzymes to synthesize retinoic acid, that is required for
proper cardiac development (Collop et al., 2006; Drysdale and Crawford, 1994; Jiang et
al., 1999; Keegan et al., 2005; Smith et al., 1997; Twal et al., 1995; Xavier-Neto et al.,
2000). The enzymes alcohol dehydrogenase (ADH) and aldehyde dehydrogenase
(ALDH), in this situation Raldh2, are necessary for the synthesis of RA from retinol
(Boleda et al., 1993; Connor and Smit, 1987; Yang et al., 1994). However, this may be
competitively inhibited by the presence of ethanol, which requires these enzymes for
detoxification (Duester, 1991; Mezey and Holt, 1971; Van Thiel et al., 1974). Therefore,
the presence of ethanol could result in an overall decrease in RA levels.
This hypothesis is supported by the recapitulation in phenotype resulting from both RA
deficiency and ethanol-induced teratogenesis (Cartwright and Smith, 1995b; Dickman et
al., 1997; Gale et al., 1996; Johnson et al., 1996; Maden et al., 1996; Yelin et al., 2005;
Yelin et al., 2007a). Exogenous retinoic acid administration resulted in Xenopus embryos
with the opposite gene expression profile to embryos exposed to ethanol, such as

115

differential expression of hoxA2, hoxB4, hoxB9, gsc, otx2, and chordin (Yelin et al.,
2005). This proposition was further supported by over expression of cyp26, which is an
enzyme that degrades RA. Cyp26 over expression resulted in a similar phenotype to FAS
in Xenopus embryos. Furthermore, co-exposure with retinoic acid and ethanol resulted in
a phenotypic rescue in both Xenopus and quail embryos (Twal et al., 1997; Yelin et al.,
2005).
These defects did not result from an increased metabolism of retinoic acid as a
contrasting reduction in cyp26 expression was observed following ethanol administration
(Yelin et al., 2005). Although cyp2E1 is another enzyme involved in ethanol metabolism
and free radical synthesis, this gene is not activated at a relevant developmental interval
(Deltour et al., 1996). Following analysis of my data, I also noticed that both the RAA
and ethanol treatment caused similar reductions in ventricular morphology and function,
which supports the hypothesis that the teratogenic consequences induced by ethanol
exposure could be caused by a reduction in retinoic acid levels.

4.3 Origin of Cardiac Response
I pursued to answer a distinct and unique question not related to CHDs, although this
experiment still served the purpose of establishing this novel imaging system’s
usefulness. I sought to determine the time at which cardiac response originates, which
possibly initiates upon the completion of innervation. Xenopus has historically served as
a valuable model for studying developmental biology, however, the timing of initiating
the cardiac response has not, to our knowledge, been established.
Future experiments should investigate developmental intervals preceding stage 37/38. A
caveat of this technique is that the heartbeat must be present to examine innervation.
Since coordinated myocardial contractions commence in the primitive heart at
approximately stage 35, when cardiac looping is finishing, then innervation cannot be
studied prior to this stage using this method (Lohr and Yost, 2000; Warkman and Krieg,
2007). A developmental window that is worth investigating would be stages 35 and 36.
Imaging at this stage may be possible through manipulation of the embryo by physically
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removing the ectodermal layers that are positioned ventral to the heart, which would
resolve optical constraints that I encountered in my experiments.
I acutely exposed embryos to classical modulators of heart rate to attempt to narrow
down the developmental window that corresponds to the initiation of innervation. The
rationale follows that if embryos are responsive to a drug at a certain stage, then
innervation has probably occurred allowing the embryo to display the appropriate cardiac
response in the presence of the pharmacological agent.
Due to limitations of this system, I was not able to precisely identify the origin of cardiac
response. Nevertheless, I was capable of narrowing the developmental window by
identifying that innervation originates by at least stage 37/38, which is following the
completion of cardiac differentiation and looping (Kolker et al., 2000; Lohr and Yost,
2000; Mohun et al., 2000).

4.4 Advantages
I will now review the video imaging system as a method of analyzing cardiac function,
including both the advantages and limitations.
Firstly, there are numerous advantages of the techniques and system that I have used in
studying the early heart and it can be a particularly useful alternative to current imaging
modalities. Two important advantages of using Xenopus are the ability to view the
embryo from the ventral side without manipulation and the ability of the embryo to
survive without a properly functioning heart until later tadpole stages (Kaltenbrun et al.,
2011; Mohun et al., 2000).
There are several advantages of the mounting protocol that I used (Kieserman et al.,
2010). Some of the highlights include the ability to re-use an embryo for acute drug
exposure studies or for longitudinal studies examining maturation. This procedure is noninvasive, therefore should not affect cardiac function and anesthetization is unnecessary.
Furthermore, modifications to this mounting protocol allows for relatively long-term live
imaging without embryo desiccation.
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This novel imaging system offers several advantages compared to current imaging
modalities. For instance, the cost of the software and the video camera is far less
expensive compared to other equipment, such as magnetic resonance imaging or confocal
microscopy. The level of expertise required to use the software and equipment is much
less extensive than that expected of other modalities such as MRI, ultrasound,
echocardiography, optical coherence tomography, and intrathoracic cardiac recording.
Certain imaging modalities require further expertise since the images are more subjective
and difficult to interpret compared to the higher resolution images that are obtained using
our video imaging system. However, the relatively high-resolution images do not require
a low frame-rate, which is very useful for studying a rapidly beating heart. The ability to
analyze real-time videos is also useful compared to modalities that require embryo
fixation, such as scanning electron microscopy and 3D reconstructions using histological
sections. Simple normal light optics is used to visualize the heart since the camera uses
endogenous hemoglobin to create contrast. This is less invasive compared to other
imaging modalities that require the use of exogenously labeled dyes to create sufficient
contrast to obtain an image.
Our video imaging system offers significant advantages compared to current imaging
modalities. However, this imaging system is not without caveats, which will be addressed
in the next section.

4.5 Limitations
As noted previously, only four stages of embryonic development for the normative
sample were ideal for functional examination using this system. These stages included
the later stages of development once cardiac morphology is relatively established (Mohun
et al., 2000). These limitations arise due to optical considerations, since this system does
not manipulate the embryo and uses normal light optics.
Development before stage 45 is difficult to measure due to ectodermal pigmentation and
general opacity on the ventral side surrounding the heart. Although beating hearts could
be seen, there was difficulty in establishing a clear outline of the epicardial and
endocardial borders. As well, decreased presence of blood and blood flow creates
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difficulty in tracing the endocardial border since hemoglobin was important for creating
contrast (Movie 19). Subsequently, during development in later stage 48 and onwards,
the myocardium has substantially thickened and the working distance from the ventral
surface to the heart increased causing the cardiac borders to again be difficult to
distinguish accurately (Movie 20) (Wessels and Sedmera, 2003).
Limitations were also present for the experiments examining the origin of cardiac
response, however, distinct endocardial and epicardial borders were not as rigorously
required for investigation of only heart rate. This was nevertheless challenging due to the
presence of the pigmentation and opacity on the ventral and lateral ectoderm surrounding
the heart, that resulted in measurement difficulty prior to stage 40. By exploiting the
Nkx2.5-GFP transgenic line, I could visualize the heart at earlier stages (stages 37-39)
using a fluorescent stereomicroscope. These stages were not imaged using the Flare
camera and HeartMetrics software as this system required an abundance of light for
visualization, which prohibited the use of fluorescence. Even so, earlier measurements
are still challenging due to the ectodermal covering.
Embryos that were chronically exposed to various treatments were challenging to
examine and limited the parameters that could be studied. The dorsal side became curved
causing difficulty in viewing the ventral side without embryo manipulation. Furthermore,
the pericardial edema located on the ventral side that is normally associated with these
treatments caused an increased working distance as the heart became located more
dorsally, making ventral imaging more difficult. Therefore, cardiac function was
examined exclusively at end-diastole following exposure to small molecules, resulting in
the omission of key parameters, such as stroke volume and cardiac output.

4.6 Significance
The video imaging system that I used can measure cardiac function even following
exposure to small molecules that disrupt cardiogenesis, therefore, this system may be a
useful alternative to current imaging modalities. Using this system, understanding the
contribution of functional changes due to or causing CHDs may be easier to examine. As
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well, the association between normal morphogenesis and function may be simpler to
assess.
A future aspiration would be to create a fully automated high-throughput system that is
capable of using this system to quickly analyze hundreds of compounds for cardiac
activity. This may provide the ability to screen for novel compounds that are capable of
causing disruptions in cardiogenesis or alterations in cardiac function.
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Appendix

Figure A1. Examination of end-diastolic dimension and end-systolic dimension for
Xenopus laevis embryos at stage 47. The end-diastolic dimension (EDD) and endsystolic dimension (ESD) were examined for stage 47 Xenopus laevis embryos. These
ventricular dimensions included the measurement of both the ventricular cavity and the
ventricular wall. n = 50
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